Skip navigation

Zinc


What is it?

Zinc is a metal. It is called an “essential trace element” because very small amounts of zinc are necessary for human health.

Zinc is used for treatment and prevention of zinc deficiency and its consequences, including stunted growth and acute diarrhea in children, and slow wound healing.

It is also used for boosting the immune system, treating the common cold and recurrent ear infections, and preventing lower respiratory infections. It is also used for malaria and other diseases caused by parasites.

Some people use zinc for an eye disease called macular degeneration, for night blindness, and for cataracts. It is also used for asthma; diabetes; high blood pressure; acquired immunodeficiency syndrome (AIDS); and skin conditions such as psoriasis, eczema, and acne.

Other uses include treating attention deficit-hyperactivity disorder (ADHD), blunted sense of taste (hypogeusia), ringing in the ears (tinnitus), severe head injuries, Crohn’s disease, Alzheimer’s disease, Down syndrome, Hansen’s disease, ulcerative colitis, peptic ulcers and promoting weight gain in people with eating disorders such as anorexia nervosa.

Some people use zinc for benign prostatic hyperplasia (BPH), male infertility, erectile dysfunction (ED), weak bones (osteoporosis), rheumatoid arthritis, and muscle cramps associated with liver disease. It is also used for sickle cell disease and inherited disorders such as acrodermatitis enteropathica, thalassemia, and Wilson’s disease.

Some athletes use zinc for improving athletic performance and strength.

Zinc is also applied to the skin for treating acne, aging skin, herpes simplex infections, and to speed wound healing.

There is a zinc preparation that can be sprayed in the nostrils for treating the common cold.

Zinc sulfate is used in products for eye irritation.

Zinc citrate is used in toothpaste and mouthwash to prevent dental plaque formation and gingivitis.

Note that many zinc products also contain another metal called cadmium. This is because zinc and cadmium are chemically similar and often occur together in nature. Exposure to high levels of cadmium over a long time can lead to kidney failure. The concentration of cadmium in zinc-containing supplements can vary as much as 37-fold. Look for zinc-gluconate products. Zinc gluconate consistently contains the lowest cadmium levels.

How effective is it?

Natural Medicines Comprehensive Database rates effectiveness based on scientific evidence according to the following scale: Effective, Likely Effective, Possibly Effective, Possibly Ineffective, Likely Ineffective, Ineffective, and Insufficient Evidence to Rate.

The effectiveness ratings for ZINC are as follows:

Effective for...

  • Zinc deficiency. Zinc deficiency might occur in people with severe diarrhea, conditions that make it hard for the bowel to absorb food, liver cirrhosis and alcoholism, after major surgery, and during long-term use of tube feeding in the hospital. Taking zinc by mouth or giving zinc intravenously (by IV) helps to restore zinc levels in people who are zinc deficient. However, taking zinc supplements regularly is not recommended.

Likely effective for...

  • Diarrhea. Taking zinc by mouth reduces the duration and severity of diarrhea in children who are undernourished or zinc deficient. Severe zinc deficiency in children is common in developing countries.
  • An inherited disorder called Wilson’s disease. Taking zinc by mouth improves symptoms of an inherited disorder called Wilson’s disease. People with Wilson’s disease have too much copper in their bodies. Zinc blocks how much copper is absorbed and increases how much copper the body releases.

Possibly effective for...

  • Acne. Research suggests that people with acne have lower blood and skin levels of zinc. Taking zinc by mouth appears to help treat acne. However, applying zinc to the skin in an ointment does not seem to help treat acne uless used in combination with the antibiotic drug called erythromycin.
  • An inherited disorder that affects zinc uptake (acrodermatitis enteropathica). Taking zinc by mouth seems to help improve symptoms of acrodermatitis enteropathica.
  • Age-related vision loss (age-related macular degeneration). Taking zinc by mouth might reduce the risk of developing age-related vision loss. Also, taking zinc by mouth together with antioxidant vitamins appears to slow the progression of advanced age-related vision loss. However, taking zinc by mouth alone does not seem to benefit people with age-related vision loss that is not yet advanced.
  • Anemia. Giving a porridge that contains zinc and other vitamins and minerals to infants appears to reduce the risk of anemia.
  • Anorexia. Taking zinc supplements by mouth might help increase weight gain and improve depression symptoms in people with anorexia.
  • Attention deficit-hyperactivity disorder (ADHD). Taking zinc by mouth in combination with conventional treatment might slightly improve symptoms of hyperactivity, impulsiveness, and socialization problems in some children with ADHD. However, zinc might not improve attention span. Some research suggests that children with ADHD have lower zinc levels in their blood than children without ADHD. Other research suggests people with ADHD with lower zinc levels might not respond well enough to prescription medications for ADHD (stimulants). Studies using zinc for ADHD have taken place in the Middle East where zinc deficiency is relatively common compared to Western countries. It is not known if zinc would have the same potential benefits when used for ADHD in people from Western countries.
  • Burns. Giving zinc intravenously (by IV) together with other minerals seems to improve wound healing in people with burns.However, taking zinc alone does not appear to improve wound healing, although it does seem to reduce recovery time.
  • Common cold. Taking lozenges containing zinc gluconate or zinc acetate by mouth seems to help decrease the duration of a cold in adults, although some conflicting evidence exists. Taking zinc supplements by mouth does not appear to prevent common colds in adults. However, zinc gluconate lozenges might help prevent colds in children and adolescents. Using zinc as a nose spray does not seem to help prevent colds
  • Dandruff. Using a zinc pyrithione shampoo appears to reduce dandruff.
  • Depression. Research suggests that taking zinc along with antidepressants seems to improve depression in people with major depression and those who do not respond to treatment with antidepressants alone.
  • Foot ulcers due to diabetes. Research suggests that applying zinc hyaluronate gel can help ulcers heal faster than conventional treatment.
  • Diaper rash. Giving zinc gluconate by mouth or applying zinc oxide paste to infants with diaper rash appears to improve rash healing.
  • Esophageal cancer. Early research has linked low intake of zinc with an increased risk of esophageal cancer.
  • Gingivitis. Using toothpastes containing zinc, with or without an antibacterial agent, appears to prevent plaque and gingivitis. Some evidence also shows that zinc-containing toothpaste can reduce existing plaque. However, other conventional treatments may be more effective.
  • Bad breath. Research suggests that chewing gum containing zinc reduces bad breath.
  • Herpes simplex virus. Applying zinc sulfate or zinc oxide to the skin, alone or with other ingredients, seems to reduce the duration and severity of oral and genital herpes. However, zinc might not be beneficial for recurrent herpes infections.
  • Taste disorder (hypogeusia). Taking zinc by mouth appears to be effective for people with a reduced ability to taste foods due to zinc deficiency or some other conditions.
  • Skin lesions (Leishmania lesions). Research suggests that taking zinc sulfate by mouth or injecting as a solution into lesions helps heal lesions in people with Leishmaniasis. However, zinc may not be more effective than conventional treatments.
  • Leprosy. Taking zinc by mouth in combination with anti-leprosy drugs seems to help treat leprosy.
  • Muscle cramps. Taking zinc by mouth in people with cirrhosis and zinc deficiency seems to help treat muscle cramps.
  • Swelling and ulcers in the mouth caused by radiation therapy. Taking zinc sulfate by mouth seems to be effective for treating ulcers and swelling in the mouth caused by radiation treatments.
  • Weak bones (osteoporosis). Low zinc intake seems to be linked to lower bone mass. Taking a zinc supplement in combination with copper, manganese, and calcium might decrease bone loss in women who have passed menopause.
  • Peptic ulcers. Taking zinc acexamate by mouth seems to help treat and prevent peptic ulcers. This form of zinc is not available in the US.
  • Pneumonia. Some research shows that giving zinc supplements to undernourished children reduces the risk of developing pneumonia. However, the effects of zinc for treating pneumonia once it develops are inconsistent.
  • Complications during pregnancy. Taking zinc by mouth during pregnancy appears to reduce the risk for early delivery. However, zinc supplementation does not seem to reduce the risk for stillbirths or infant deaths. Taking zinc with vitamin A might help restore night vision in pregnant women affected by night blindness. However, taking zinc alone does not appear to have this effect.
  • Pressure ulcers. Taking zinc by mouth or applying zinc paste appears to help improve pressure ulcer healing.
  • Prostate swelling (prostatis). Research suggests that taking zinc, selenium, and iodide along with conventional treatment improves symptoms of prostatitis, including pain and quality of life, compared to conventional treatment alone.
  • Severe infection complication (sepsis). Research shows that administering a specific product containing zinc (Intestamin) can decrease the risk for organ failure in people with sepsis.
  • Food poisoning (shigellosis). Research shows that taking a multivitamin syrup containing zinc along with conventional treatment can improve recovery time and reduce diarrhea in undernourished children with food poisoning.
  • Sickle cell disease. Taking zinc by mouth seems to help reduce symptoms of sickle cell disease in people with zinc deficiency. Taking zinc supplements also appears to decrease the risk for complications and infections related to sickle cell disease.
  • Leg ulcers. Taking zinc sulfate by mouth appears to help some types of leg ulcers heal faster. The effects seem to be greater in people with low levels of zinc before treatment. Applying zinc paste to leg ulcers also appears to improve healing.
  • Vitamin A deficiency. Taking zinc by mouth together with vitamin A seems to improve vitamin A levels in undernourished children better than vitamin A or zinc alone.
  • Warts. Early research suggests that applying a zinc sulfate solution improves plane warts but not common warts. Applying zinc oxide ointment appears to be as effective as conventional treatments for curing warts. Taking zinc sulfate by mouth also appears to be effective.

Possibly ineffective for...

  • AIDS diarrhea-wasting syndrome. Taking zinc by mouth together with vitamins does not seem to improve AIDS diarrhea-wasting syndrome.
  • Hair loss. Although there is early evidence that suggests taking zinc together with biotin might be helpful for hair loss, most studies suggest that zinc is not effective for this condition.
  • Scaly, itchy skin (eczema). Taking zinc by mouth does not appear to improve skin redness or itching in children with eczema.
  • Cataracts. Taking zinc by mouth together with antioxidant vitamins does not seem to help treat or prevent cataracts.
  • Cystic fibrosis. Zinc sulfate does not appear to improve lung function in children or adolescents with cystic fibrosis, although it may reduce the need for antibiotics.
  • HIV. Taking zinc by mouth along with antiretroviral therapy does not improve immune function or reduce the risk of death in adults or children with HIV.
  • Pregnancy complications in women with HIV. Taking zinc by mouth during pregnancy does not appear to reduce the risk of transmitting HIV to the infant. Also, zinc does not appear to prevent infant death or maternal wasting in pregnant women with HIV.
  • Infant development. Giving zinc to infants does not improve mental or motor development.
  • Inflammatory bowel disease (IBD). Taking zinc by mouth does not seem to help treat IBD.
  • Flu. Taking zinc supplements by mouth is unlikely to improve immune function in people who are not at risk for zinc deficiency.
  • Ear infection. Taking zinc does not appear to prevent ear infections in children.
  • Iron-deficiency during pregnancy. Taking zinc by mouth does not seem to help improve iron levels in women taking iron and folic acid supplements.
  • Prostate cancer. Early research suggests that taking zinc along with other vitamins and minerals may prevent prostate cancer in some men. However, other research suggests that taking zinc can increase the risk of developing prostate cancer and increase the risk of dying from prostate cancer.
  • Red and irritated skin (psoriasis). Taking zinc by mouth does not seem to help treat psoriasis.
  • Joint inflammation associated with a specific skin condition (psoriatic arthritis). Taking zinc by mouth, alone or together with painkillers, has no effect on the progression of psoriatic arthritis.
  • Joint inflammation (rheumatoid arthritis). Taking zinc by mouth does not seem to help treat rheumatoid arthritis.
  • Sexual dysfunction. Research suggests that zinc supplementation does not improve sexual function in men with sexual dysfunction related to kidney disease.
  • Ringing in the ears (tinnitus). Taking zinc by mouth does not seem to help treating ringing in the ears.
  • Upper respiratory tract infections. Taking zinc by mouth does not decrease the risk for upper respiratory tract infections.

Likely ineffective for...

  • Malaria. Taking zinc by mouth does not seem to help prevent or treat malaria in undernourished children in developing countries.

Insufficient evidence to rate effectiveness for...

  • AIDS-related infections due to weakened immunity. There is some early evidence that taking zinc supplements by mouth in combination with the drug zidovudine might reduce infections that occur because of a weakened immune system.
  • Alcohol-related liver disease. Taking zinc sulfate by mouth might improve liver function in people with alcohol-related liver disease.
  • Alzheimer’s disease. Some early research shows that zinc supplements might slow the worsening of symptoms in people with Alzheimer’s disease.
  • Arsenic poisoning. Early research suggests that taking zinc together with spirulina can reduce symptoms and arsenic levels in the urine and hair of people with long-term arsenic poisoning.
  • Asthma. Zinc intake does not appear to be linked to the risk for developing asthma in children.
  • A blood disorder called beta-thalassemia. Early research suggests that taking zinc sulfate along with blood transfusions increases growth in children with beta-thalassemia compared to blood transfusions alone.
  • Brain cancer. Early research suggests that zinc intake is not linked with a reduced risk of developing brain cancer.
  • Canker sores. Some early research suggests that taking zinc sulfate improves canker sores and prevents them from reappearing. However, other research shows no benefit.
  • A lung disease called chronic obstructive pulmonary disorder (COPD). Early research suggests that taking zinc daily after recovery from COPD-related infections reduces the risk of additional infections in older people.
  • Clogged arteries (coronary artery disease). Early research suggests that taking zinc reduces cholesterol but not triglycerides in people with clogged arteries.
  • Memory loss (dementia). Research suggests that taking zinc sulfate improves behavior and social abilities in people with memory loss.
  • Dental plaque. Early evidence suggests that brushing teeth with toothpaste containing zinc reduces plaque buildup.
  • Nerve damage caused by diabetes (diabetic neuropathy). Research suggests that taking zinc sulfate improves nerve function and reduces blood sugar in people with nerve damage caused by diabetes.
  • Down’s syndrome. Early research suggests that taking zinc can improve immune function and reduce infections in people with Down’s syndrome and weakened immune systems. However, other research shows conflicting results.
  • Head and neck cancer. Research suggests that zinc supplementation does not improve survival rates after 3 years in people with head and neck cancer. However, zinc might improve survival rates after 5 years
  • Loss in brain function due to liver problems (Hepatic encephalopathy). Research suggests that taking zinc acetate improves some measures of mental function in people with hepatic encephalopathy. However, other research suggests that zinc sulfate does not improve brain function in people with this condition.
  • HIV-related diarrhea. Research suggests that taking zinc can reduce the risk of having diarrhea in adults and children with HIV. However, other research suggests that zinc might not be effective in adults who have had diarrhea for 7 or more days.
  • Fertility problems in men (impotence). Some early research suggests that taking zinc by mouth does not improve sperm count or sperm movement in men with fertility problems. However, other early research suggests that zinc supplementation increases sperm count, testosterone levels, and pregnancy rates in infertile men with low testosterone levels
  • Stomach infections and parasite infestations. Zinc supplementation, alone or together with vitamin A, might be effective for treating some parasite infections in children in developing countries. However, evidence is not consistent. Some research suggests that taking zinc with vitamin A reduces the risk for some infections, while other research suggests that it does not have an effect on the risk for infection.
  • Death during childhood. Research suggests that supplementing pregnant women in Nepal with zinc, folic acid, vitamin A, and iron does not reduce the risk of childhood death by the age of 7 years-old compared to vitamin A alone.
  • Head trauma. Administering zinc immediately after a head trauma seems to improve the rate of recovery.
  • A type of cancer called non-Hodgkin’s lymphoma. Research suggests that zinc supplementation is linked to a decreased risk of developing non-Hodgkin’s lymphoma
  • Full-term newborns that are too small. Research suggests that taking zinc supplements during pregnancy does not reduce the risk of having a low birth weight infant. However, adding zinc to nutritional supplementation for underweight, full-term infants in developing countries seems to decrease the risk of death. Also, some research suggests that zinc supplementation increases birth weight and length. However, other research shows no benefit.
  • Recovery after surgery. Early research suggests that taking zinc by mouth can reduce healing time after surgery.
  • A skin disease called tinea versicolor. Research suggests that using a zinc shampoo once daily for 14 days seems to reduce a fungal skin infection that causes tinea versicolor.
  • Wrinkled skin. A skin cream containing 10% vitamin C as L-ascorbic acid and acetyl tyrosine, zinc sulfate, sodium hyaluronate, and bioflavonoids (Cellex-C High Potency Serum) applied for 3 months to facial skin aged by sun exposure seems to improve fine and coarse wrinkling, yellowing, roughness, and skin tone.
  • Crohn’s disease.
  • Ulcerative colitis.
  • Other conditions.
More evidence is needed to rate zinc for these uses.

How does it work?

Return to top
Zinc is needed for the proper growth and maintenance of the human body. It is found in several systems and biological reactions, and it is needed for immune function, wound healing, blood clotting, thyroid function, and much more. Meats, seafood, dairy products, nuts, legumes, and whole grains offer relatively high levels of zinc.

Zinc deficiency is not uncommon worldwide, but is rare in the US. Symptoms include slowed growth, low insulin levels, loss of appetite, irritability, generalized hair loss, rough and dry skin, slow wound healing, poor sense of taste and smell, diarrhea, and nausea. Moderate zinc deficiency is associated with disorders of the intestine which interfere with food absorption (malabsorption syndromes), alcoholism, chronic kidney failure, and chronic debilitating diseases.

Zinc plays a key role in maintaining vision, and it is present in high concentrations in the eye. Zinc deficiency can alter vision, and severe deficiency can cause changes in the retina (the back of the eye where an image is focused).

Zinc might also have effects against viruses. It appears to lessen symptoms of the rhinovirus (common cold), but researchers can’t yet explain exactly how this works. In addition, there is some evidence that zinc has some antiviral activity against the herpes virus.

Low zinc levels can be associated with male infertility, sickle cell disease, HIV, major depression, and type 2 diabetes, and can be fought by taking a zinc supplement.

Are there safety concerns?

Return to top
Zinc is LIKELY SAFEfor most adults when applied to the skin, or when taken by mouth in amounts not larger than 40 mg daily. Routine zinc supplementation is not recommended without the advice of a healthcare professional. In some people, zinc might cause nausea, vomiting, diarrhea, metallic taste, kidney and stomach damage, and other side effects. Using zinc on broken skin may cause burning, stinging, itching, and tingling.

Zinc is POSSIBLY SAFE when taking by mouth in doses greater than 40 mg daily. There is some concern that taking doses higher than 40 mg daily might decrease how much copper the body absorbs. Decreased copper absorption may cause anemia.

Zinc is POSSIBLY UNSAFE when inhaled through the nose, as it might cause permanent loss of smell. In June 2009, the US Food and Drug Administration (FDA) advised consumers not to use certain zinc-containing nose sprays (Zicam) after receiving over 100 reports of loss of smell. The maker of these zinc-containing nose sprays has also received several hundred reports of loss of smell from people who had used the products. Avoid using nose sprays containing zinc.

Taking high amounts of zinc is LIKELY UNSAFE. High doses above the recommended amounts might cause fever, coughing, stomach pain, fatigue, and many other problems.

Taking more than 100 mg of supplemental zinc daily or taking supplemental zinc for 10 or more years doubles the risk of developing prostate cancer. There is also concern that taking large amounts of a multivitamin plus a separate zinc supplement increases the chance of dying from prostate cancer.

Taking 450 mg or more of zinc daily can cause problems with blood iron. Single doses of 10-30 grams of zinc can be fatal.

Special precautions & warnings:

Infants and children: Zinc is LIKELY SAFE when taken by mouth appropriately in the recommended amounts. Zinc is POSSIBLY UNSAFE when used in high doses.

Pregnancy and breast-feeding: Zinc is LIKELY SAFE for most pregnant and breast-feeding women when used in the recommended daily amounts (RDA). However, zinc is POSSIBLY UNSAFE when used in high doses by breast-feeding women and LIKELY UNSAFE when used in high doses by pregnant women. Pregnant women over 18 should not take more than 40 mg of zinc per day; pregnant women age 14 to 18 should not take more than 34 mg per day. Breast-feeding women over 18 should not take more than 40 mg of zinc per day; breast-feeding women age 14 to 18 should not take more than 34 mg per day.

Alcoholism: Long-term, excessive alcohol drinking is linked to poor zinc absorption in the body.

Diabetes: Large doses of zinc can lower blood sugar in people with diabetes. People with diabetes should use zinc products cautiously.

Hemodialysis: People receiving hemodialysis treatments seem to be at risk for zinc deficiency and might require zinc supplements.

HIV (human immunodeficiency virus)/AIDS: Use zinc cautiously if you have HIV/AIDS. Zinc use has been linked to shorter survival time in people with HIV/AIDs.

Syndromes in which it is difficult for the body to absorb nutrients: People with malabsorption syndromes may be zinc deficient.

Rheumatoid arthritis (RA): People with RA aborb less zinc.

Are there interactions with medications?

Return to top

Major

Do not take this combination.

Penicillamine
Penicillamine is used for Wilson's disease and rheumatoid arthritis. Zinc might decrease how much penicillamine your body absorbs and decrease the effectiveness of penicillamine. Take zinc and penicillamine at least 2 hours apart.

Moderate

Be cautious with this combination.

Antibiotics (Quinolone antibiotics)
Zinc might decrease how much antibiotic the body absorbs. Taking zinc along with some antibiotics might decrease the effectiveness of some antibiotics. To avoid this interaction, take antibiotics at least 2 hours before or 4-6 hours after zinc supplements.

Some of these antibiotics that might interact with zinc include ciprofloxacin (Cipro), levofloxacin (Levaquin), ofloxacin (Floxin), moxifloxacin (Avelox), gatifloxacin (Tequin) enoxacin (Penetrex), norfloxacin (Chibroxin, Noroxin), sparfloxacin (Zagam), trovafloxacin (Trovan), and grepafloxacin (Raxar).

Antibiotics (Tetracycline antibiotics)
Zinc can attach to tetracyclines in the stomach. This decreases the amount of tetracyclines that can be absorbed. Taking zinc with tetracyclines might decrease the effectiveness of tetracyclines. To avoid this interaction, take tetracyclines 2 hours before or 4-6 hours after taking zinc supplements.

Some tetracyclines include demeclocycline (Declomycin), minocycline (Minocin), and tetracycline (Achromycin, Sumycin).

Cisplatin (Platinol-AQ)
Cisplatin (Platinol-AQ) is used to treat cancer. Taking zinc along with EDTA and cisplatin (Platinol-AQ) might inactivate cisplatin (Platinol-AQ) therapy. It is not known for sure, though, if the amount of interference caused by zinc is significant.

Medications for diabetes (Antidiabetes drugs)
Zinc might decrease blood sugar in people with type 2 diabetes. Diabetes medications are also used to lower blood sugar. Taking zinc along with diabetes medications might cause your blood sugar to go too low. Monitor your blood sugar closely. The dose of your diabetes medication might need to be changed.

Some medications used for diabetes include glimepiride (Amaryl), glyburide (DiaBeta, Glynase PresTab, Micronase), insulin, pioglitazone (Actos), rosiglitazone (Avandia), chlorpropamide (Diabinese), glipizide (Glucotrol), tolbutamide (Orinase), and others.

Minor

Be watchful with this combination.

Amiloride (Midamor)
Amiloride (Midamor) is used as a "water pill" to help remove excess water from the body. Another effect of amiloride (Midamor) is that it can increase the amount of zinc in the body. Taking zinc supplements with amiloride (Midamor) might cause you to have too much zinc in your body.

Are there interactions with herbs and supplements?

Return to top
Beta-carotene
High doses of zinc can lower beta-carotene blood levels.

Bromelain
Metals such as zinc might reduce the effects of bromelain. However, there are no reports of this interaction.

Calcium
Calcium supplements might decrease dietary zinc absorption. This usually doesn't seem to be much of a problem. However, this interaction can be avoided by taking calcium supplements at bedtime instead of with meals.

Chromium
There is early evidence that chromium and zinc could each reduce the absorption of the other. This is probably not a problem when usual supplemental doses of zinc and chromium are taken.

Copper
Large amounts of zinc can reduce copper absorption. Taking zinc in high doses can cause significant copper deficiency and anemia, a condition in which the blood cannot carry enough oxygen. Some signs of copper deficiency have also occurred in people taking 150 mg/day or more of zinc for 2 years.

EDTA
EDTA is a chemical compound that is given to people to remove excess metals in their systems, especially lead. EDTA works by binding with (chelating) the metal. Repeated high doses of EDTA, as used in chelation treatment, can reduce blood zinc levels by up to 40%. Symptoms of zinc depletion have been reported, even when supplemental zinc (15mg/day) was given. People receiving chelation therapy should be monitored for zinc depletion.

Folic acid
Studies on the effects of folic acid supplements on dietary zinc absorption are conflicting. Normal supplemental doses of folic acid are not likely to affect zinc balance in people with adequate dietary zinc intake.

Herbs and supplements that might lower blood sugar
Large amounts of zinc might lower blood sugar. Using it along with other herbs and supplements that have the same effect might cause blood sugar to drop too low in some people. Some of these alpha-lipoic acid, bitter melon, chromium, devil's claw, fenugreek, garlic, guar gum, horse chestnut, Panax ginseng, psyllium, Siberian ginseng, and others.

IP-6 (Phytic acid)
Phytic acid found naturally in foods can bind zinc and reduce its absorption;. howeverHowever, zinc deficiency due to high dietary phytic acid levels has not been reported in Western populations. Avoid IP-6 supplements, which contain phytic acid, if you have other risk factors for zinc deficiency.

Iron
Under some circumstances, iron and zinc can interfere with each other's absorption. To avoid this effect, take these supplements with food.

Magnesium
High doses of zinc supplements (142 mg/day), or high dietary zinc intake (53mg/day) seem to decrease magnesium balance. The importance of this isn't known.

Manganese
Research suggests zinc supplements can more than double the amount of manganese absorbed from supplements.

Riboflavin (Vitamin B2)
Research suggests riboflavin can improve zinc absorption. The importance of this isn't known.

Vitamin A
Research suggests that zinc supplements can increase blood levels of vitamin A. Theoretically, zinc might increase the effects and side effects of vitamin A.

Vitamin D
Research suggests vitamin D is involved in zinc absorption, but it's not clear whether vitamin D improves zinc absorption.

Are there interactions with foods?

Return to top
Coffee
Taking zinc sulfate with black coffee instead of water reduces zinc absorption by half. Researchers aren't sure why this happens or how important the interaction may be.

Dairy products, calcium-fortified foods
Calcium can decrease zinc absorption. The risk of losing too much zinc isn't significant unless lots of dairy products are consumed along with calcium supplements. However, the body adapts over the long term, becoming more efficient at absorbing zinc and reducing zinc losses.

Fiber
Eating fiber can reduce zinc absorption. However, over time the body adapts to increased dietary fiber by increasing zinc absorption.

Phytate (Phytic acid, myoinositol hexaphosphate, IP6)
Phytate is a molecule found in grains (e.g., maize, corn, sorghum), legumes, seeds (e.g., sunflower, pumpkin), and soy. Phytate can reduce zinc absorption. Some foods with higher phytate contents also have a higher zinc content (for example, whole wheat vs. white bread), canceling out the effect in zinc absorption. Some people in Middle Eastern countries have zinc deficiencies because they eat unleavened bread and maize, which contain phytate. People in Western populations most at risk are those with diets high in unrefined grains, legumes, soy protein, and calcium, and low in animal protein. However, the body adapts over the long term, becoming more efficient at absorbing zinc and reducing zinc losses.

Protein
Zinc binds to proteins, becoming available for absorption as the protein is digested. The type of protein influences how much zinc is absorbed. Animal proteins generally increase zinc absorption, although a protein in cow's milk slows absorption down. Soy proteins also reduce zinc absorption, possibly due to their phytate content. These effects can influence zinc balance in infants; babies get the most zinc from mother's milk, less from cow's milk, and even less from soy-based milk. It isn't known whether high-protein diets influence zinc balance in adults.

Vegetarianism
Vegetarian diets are often high in grains and legumes, so they contain more phytate. Zinc absorption is likely to be lower, so this type of diet is considered a risk factor for zinc depletion. However, the body adapts over the long term, becoming more efficient at absorbing zinc and reducing zinc losses.

What dose is used?

Return to top
The following doses have been studied in scientific research:

BY MOUTH:
  • For treating the common cold: one zinc gluconate or acetate lozenge, providing 9-24 mg elemental zinc, dissolved in the mouth every two hours while awake when cold symptoms are present.
  • For diarrhea in malnourished or zinc-deficient children: 10-40 mg elemental zinc daily.
  • For preventing and treating pneumonia in undernourished children in developing countries: 10-70 mg/day.
  • For hypogeusia (sense of taste is abnormal): 25-100 mg zinc.
  • For the eating disorder anorexia nervosa: 100 mg of zinc gluconate daily.
  • For treating stomach ulcers: zinc sulfate 200 mg three times daily.
  • For muscle cramps in zinc deficient people with liver disease: zinc sulfate 220 mg twice daily.
  • For osteoporosis: 15 mg zinc combined with 5 mg manganese, 1000 mg calcium, and 2.5 mg copper has been used.
  • For sickle cell disease: zinc sulfate 220 mg three times daily.
  • To increase growth and weight gain in children with sickle cell disease who have not reached puberty: 10 mg elemental zinc per day.
  • For treating attention deficit-hyperactivity disorder (ADHD) in children: doses of zinc sulfate 55 mg (15 mg elemental zinc) to 150 mg (40 mg elemental zinc) daily.
  • For treating acne: 30-135 mg elemental zinc daily.
  • For treating age-related macular degeneration (AMD): elemental zinc 80 mg plus vitamin C 500 mg, vitamin E 400 IU, and beta-carotene 15 mg daily.
The Institute of Medicine has established Adequate Intake (AI) levels of zinc for infants birth to 6 months is 2 mg/day. For older infants, children, and adults, Recommended Dietary Allowance (RDA) quantities of zinc have been established: infants and children 7 months to 3 years, 3 mg/day; 4 to 8 years, 5 mg/day; 9 to 13 years, 8 mg/day; girls 14 to 18 years, 9 mg/day; boys and men age 14 and older, 11 mg/day; women 19 and older, 8 mg/day; pregnant women 14 to 18, 13 mg/day; pregnant women 19 and older, 11 mg/day; lactating women 14 to 18, 14 mg/day; lactating women 19 and older, 12 mg/day.

The typical North American male consumes about 13 mg/day of dietary zinc; women consume approximately 9 mg/day.

The Tolerable Upper Intake Levels (UL) of zinc for people who are not receiving zinc under medical supervision: Infants birth to 6 months, 4 mg/day; 7 to 12 months, 5 mg/day; children 1 to 3 years, 7 mg/day; 4 to 8 years, 12 mg/day; 9 to 13 years, 23 mg/day; 14 to 18 years (including pregnancy and lactation), 34 mg/day; adults 19 years and older (including pregnancy and lactation), 40 mg/day.

Different salt forms provide different amounts of elemental zinc. Zinc sulfate contains 23% elemental zinc; 220 mg zinc sulfate contains 50 mg zinc. Zinc gluconate contains 14.3% elemental zinc; 10 mg zinc gluconate contains 1.43 mg zinc.

APPLIED TO THE SKIN:
  • For acne vulgaris: zinc acetate 1.2% with erythromycin 4% as a lotion applied twice daily.
  • For herpes simplex infections: zinc sulfate 0.25% applied 8 to 10 times daily or zinc oxide 0.3% with glycine applied every 2 hours while awake.

Other names

Return to top
Acétate de Zinc, Acexamate de Zinc, Aspartate de Zinc, Atomic Number 30, Chlorure de Zinc, Citrate de Zinc, Gluconate de Zinc, Méthionine de Zinc, Monométhionine de Zinc, Numéro Atomique 30, Orotate de Zinc, Oxyde de Zinc, Picolinate de Zinc, Pyrithione de Zinc, Sulfate de Zinc, Zinc Acetate, Zinc Acexamate, Zinc Aspartate, Zinc Chloride, Zinc Citrate, Zinc Difumarate Hydrate, Zinc Gluconate, Zinc Methionine, Zinc Monomethionine, Zinc Murakab, Zinc Orotate, Zinc Oxide, Zinc Picolinate, Zinc Pyrithione, Zinc Sulfate, Zinc Sulphate, Zincum Aceticum, Zincum Gluconicum, Zincum Metallicum, Zincum Valerianicum, Zn.

Methodology

Return to top
To learn more about how this article was written, please see the Natural Medicines Comprehensive Database methodology.methodology (http://www.nlm.nih.gov/medlineplus/druginfo/natural/methodology.html).

References

Return to top
To see all references for the Zinc page, please go to http://www.nlm.nih.gov/medlineplus/druginfo/natural/982.html.

  1. Merchant, H. W., Gangarosa, L. P., Morse, P. K., Strain, W. H., and Baisden, C. R. Zinc sulfate as a preventive of recurrent aphthuos ulcers. J Dent.Res 1981;60A:6009.
  2. Nachnani, S. Reduction of oral malodor with Zinc containing Chewing gum(abstract). J Dent Res 1999;78
  3. Varas Lorenzo, M. J. Zinc acexamate and ranitidine in the short- and mid-term management of gastroduodenal ulcers. Curr Ther Res 21986;39:19-29.
  4. Cuevas, F. R., Mendez, A. A. V., and Andrade, I. C. Zinc hyaluronate effects on ulcers in diabetic patients [Spanish]. Gerokomos 2007;18:91-101.
  5. Marchesini, G., Bugianesi, E., Ronchi, M., Flamia, R., Thomaseth, K., and Pacini, G. Zinc supplementation improves glucose disposal in patients with cirrhosis. Metabolism 1998;47:792-798. View abstract.
  6. Jackson, J. L., Peterson, C., and Lesho, E. A meta-analysis of zinc salts lozenges and the common cold. Arch.Intern.Med 11-10-1997;157:2373-2376. View abstract.
  7. Fairbrother, K. J., Kowolik, M. J., Curzon, M. E., Muller, I., McKeown, S., Hill, C. M., Hannigan, C., Bartizek, R. D., and White, D. J. The comparative clinical efficacy of pyrophosphate/triclosan, copolymer/triclosan and zinc citrate/triclosan dentifrices for the reduction of supragingival calculus formation. J.Clin.Dent. 1997;8(2 Spec No):62-66. View abstract.
  8. Zinc lozenges reduce the duration of common cold symptoms. Nutr.Rev. 1997;55:82-85. View abstract.
  9. Friis, H., Ndhlovu, P., Mduluza, T., Kaondera, K., Sandstrom, B., Michaelsen, K. F., Vennervald, B. J., and Christensen, N. O. The impact of zinc supplementation on Schistosoma mansoni reinfection rate and intensities: a randomized, controlled trial among rural Zimbabwean schoolchildren. Eur.J Clin Nutr 1997;51:33-37. View abstract.
  10. Esmaeli, B., Burnstine, M. A., Martonyi, C. L., Sugar, A., Johnson, V., and Brewer, G. J. Regression of Kayser-Fleischer rings during oral zinc therapy: correlation with systemic manifestations of Wilson's disease. Cornea 1996;15:582-588. View abstract.
  1. Folwaczny, C. [Role of zinc in treatment of acute diarrhea]. Z.Gastroenterol. 1996;34:260-262. View abstract.
  2. Scholl, T. O., Hediger, M. L., Schall, J. I., Fischer, R. L., and Khoo, C. S. Low zinc intake during pregnancy: its association with preterm and very preterm delivery. Am.J Epidemiol. 5-15-1993;137:1115-1124. View abstract.
  3. Castillo-Duran, C., Rodriguez, A., Venegas, G., Alvarez, P., and Icaza, G. Zinc supplementation and growth of infants born small for gestational age. J.Pediatr. 1995;127:206-211. View abstract.
  4. Floersheim, G. L. and Lais, E. [Lack of effect of oral zinc sulfate on wound healing in leg ulcer]. Schweiz.Med Wochenschr. 7-26-1980;110:1138-1145. View abstract.
  5. Netter, A., Hartoma, R., and Nahoul, K. Effect of zinc administration on plasma testosterone, dihydrotestosterone, and sperm count. Arch Androl 1981;7:69-73. View abstract.
  6. Eggert, J. V., Siegler, R. L., and Edomkesmalee, E. Zinc supplementation in chronic renal failure. Int.J.Pediatr.Nephrol. 1982;3:21-24. View abstract.
  7. Menkes, C. J., Job, Ch, Buneaux, F., and Delbarre, F. [Treatment of rheumatoid arthritis with zinc sulfate. Results of a doubl-blind trial]. Rev.Rhum.Mal Osteoartic. 1981;48:223-227. View abstract.
  8. Addy, M., Richards, J., and Williams, G. Effects of a zinc citrate mouthwash on dental plaque and salivary bacteria. J.Clin.Periodontol. 1980;7:309-315. View abstract.
  9. Zetin, M. and Stone, R. A. Effects of zinc in chronic hemodialysis. Clin Nephrol. 1980;13:20-25. View abstract.
  10. Mattingly, P. C. and Mowat, A. G. Zinc sulphate in rheumatoid arthritis. Ann.Rheum.Dis. 1982;41:456-457. View abstract.
  11. Prasad, A. S. and Cossack, Z. T. Zinc supplementation and growth in sickle cell disease. Ann Intern Med 1984;100:367-371. View abstract.
  12. Dahl, H., Norskov, K., Peitersen, E., and Hilden, J. Zinc therapy of acetazolamide-induced side-effects. Acta Ophthalmol.(Copenh) 1984;62:739-745. View abstract.
  13. Sprenger, K. B., Schmitz, J., Hetzel, D., Bundschu, D., and Franz, H. E. Zinc and sexual dysfunction. Contrib.Nephrol. 1984;38:119-128. View abstract.
  14. Fahim, M. S. and Brawner, T. A. Treatment of genital herpes simplex virus in male patients. Arch.Androl 1980;4:79-85. View abstract.
  15. Reding, P., Duchateau, J., and Bataille, C. Oral zinc supplementation improves hepatic encephalopathy. Results of a randomised controlled trial. Lancet 9-1-1984;2:493-495. View abstract.
  16. Barcia, P. J. Lack of acceleration of healing with zinc sulfate. Ann.Surg. 1970;172:1048-1050. View abstract.
  17. Voorhees, J. J., Chakrabarti, S. G., Botero, F., Miedler, L., and Harrell, E. R. Zinc therapy and distribution in psoriasis. Arch.Dermatol. 1969;100:669-673. View abstract.
  18. Czerwinski, A. W., Clark, M. L., Serafetinides, E. A., Perrier, C., and Huber, W. Safety and efficacy of zinc sulfate in geriatric patients. Clin Pharmacol.Ther. 1974;15:436-441. View abstract.
  19. Husain, S. L. Oral zinc sulphate in leg ulcers. Lancet 5-31-1969;1:1069-1071. View abstract.
  20. Pories, W. J., Henzel, J. H., Rob, C. G., and Strain, W. H. Acceleration of wound healing in man with zinc sulphate given by mouth. Lancet 1-21-1967;1:121-124. View abstract.
  21. Serjeant, G. R., Galloway, R. E., and Gueri, M. C. Oral zinc sulphate in sickle-cell ulcers. Lancet 10-31-1970;2:891-892. View abstract.
  22. Agren, M. S. and Stromberg, H. E. Topical treatment of pressure ulcers. A randomized comparative trial of Varidase and zinc oxide. Scand.J.Plast.Reconstr.Surg. 1985;19:97-100. View abstract.
  23. Graham, R. M., James, M. P., and Bennett, S. Low concentration zinc sulphate solution in the management of recurrent herpes simplex infection. Br.J.Dermatol. 1985;112:123-124. View abstract.
  24. Arcasoy, A., Cavdar, A., Cin, S., Erten, J., Babacan, E., Gozdasoglu, S., and Akar, N. Effects of zinc supplementation on linear growth in beta-thalassemia (a new approach). Am J Hematol. 1987;24:127-136. View abstract.
  25. Hill, G. M., Brewer, G. J., Juni, J. E., Prasad, A. S., and Dick, R. D. Treatment of Wilson's disease with zinc. II. Validation of oral 64copper with copper balance. Am J Med Sci 1986;292:344-349. View abstract.
  26. Weismann, K., Christensen, E., and Dreyer, V. Zinc supplementation in alcoholic cirrhosis. A double-blind clinical trial. Acta Med Scand. 1979;205:361-366. View abstract.
  27. Takihara, H., Cosentino, M. J., and Cockett, A. T. Zinc sulfate therapy for infertile male with or without varicocelectomy. Urology 1987;29:638-641. View abstract.
  28. Saxton, C. A., Harrap, G. J., and Lloyd, A. M. The effect of dentifrices containing zinc citrate on plaque growth and oral zinc levels. J.Clin.Periodontol. 1986;13:301-306. View abstract.
  29. Hustead, V. A., Greger, J. L., and Gutcher, G. R. Zinc supplementation and plasma concentration of vitamin A in preterm infants. Am.J.Clin.Nutr. 1988;47:1017-1021. View abstract.
  30. Shah, D. R., Singh, P. P., Gupta, R. C., and Bhandari, T. K. Effect of oral zinc sulphate on serum lipids and lipoproteins in human subjects. Indian J Physiol Pharmacol. 1988;32:47-50. View abstract.
  31. Cochran, R. J., Tucker, S. B., and Flannigan, S. A. Topical zinc therapy for acne vulgaris. Int.J Dermatol. 1985;24:188-190. View abstract.
  32. Marks, R., Pearse, A. D., and Walker, A. P. The effects of a shampoo containing zinc pyrithione on the control of dandruff. Br.J.Dermatol. 1985;112:415-422. View abstract.
  33. Franceschi, C., Chiricolo, M., Licastro, F., Zannotti, M., Masi, M., Mocchegiani, E., and Fabris, N. Oral zinc supplementation in Down's syndrome: restoration of thymic endocrine activity and of some immune defects. J Ment.Defic.Res 1988;32 ( Pt 3):169-181. View abstract.
  34. Alcala-Santaella, R., Castellanos, D., Velo, J. L., and Gonzalez, Lara, V. Zinc acexamate in treatment of duocenal ulcer. Lancet 7-20-1985;2:157. View abstract.
  35. Collipp, P. J. Effect of oral zinc supplements on diaper rash in normal infants. J Med Assoc.Ga 1989;78:621-623. View abstract.
  36. Lockitch, G., Puterman, M., Godolphin, W., Sheps, S., Tingle, A. J., and Quigley, G. Infection and immunity in Down syndrome: a trial of long-term low oral doses of zinc. J.Pediatr. 1989;114:781-787. View abstract.
  37. Mori, R., Ota, E., Middleton, P., Tobe-Gai, R., Mahomed, K., and Bhutta, Z. A. Zinc supplementation for improving pregnancy and infant outcome. Cochrane.Database.Syst.Rev. 2012;7:CD000230. View abstract.
  38. Lazzerini, M. and Ronfani, L. Oral zinc for treating diarrhoea in children. Cochrane.Database.Syst.Rev. 2012;6:CD005436. View abstract.
  39. Gulani, A. and Sachdev, H. S. Zinc supplements for preventing otitis media. Cochrane.Database.Syst.Rev. 2012;4:CD006639. View abstract.
  40. Picot, J., Hartwell, D., Harris, P., Mendes, D., Clegg, A. J., and Takeda, A. The effectiveness of interventions to treat severe acute malnutrition in young children: a systematic review. Health Technol.Assess. 2012;16:1-316. View abstract.
  41. Han, C. M. [Changes in body zinc and copper levels in severely burned patients and the effects of oral administration of ZnSO4 by a double-blind method]. Zhonghua Zheng.Xing.Shao Shang Wai Ke.Za Zhi. 1990;6:83-6, 155. View abstract.
  42. Haider, B. A., Lassi, Z. S., Ahmed, A., and Bhutta, Z. A. Zinc supplementation as an adjunct to antibiotics in the treatment of pneumonia in children 2 to 59 months of age. Cochrane.Database.Syst.Rev. 2011;:CD007368. View abstract.
  43. Valavi, E., Hakimzadeh, M., Shamsizadeh, A., Aminzadeh, M., and Alghasi, A. The efficacy of zinc supplementation on outcome of children with severe pneumonia. A randomized double-blind placebo-controlled clinical trial. Indian J Pediatr. 2011;78:1079-1084. View abstract.
  44. Ganguly, A., Chakraborty, S., Datta, K., Hazra, A., Datta, S., and Chakraborty, J. A randomized controlled trial of oral zinc in acute pneumonia in children aged between 2 months to 5 years. Indian J Pediatr. 2011;78:1085-1090. View abstract.
  45. Gebreselassie, S. G. and Gashe, F. E. A systematic review of effect of prenatal zinc supplementation on birthweight: meta-analysis of 17 randomized controlled trials. J Health Popul.Nutr. 2011;29:134-140. View abstract.
  46. Patel, A. B., Mamtani, M., Badhoniya, N., and Kulkarni, H. What zinc supplementation does and does not achieve in diarrhea prevention: a systematic review and meta-analysis. BMC.Infect.Dis. 2011;11:122. View abstract.
  47. Yakoob, M. Y., Theodoratou, E., Jabeen, A., Imdad, A., Eisele, T. P., Ferguson, J., Jhass, A., Rudan, I., Campbell, H., Black, R. E., and Bhutta, Z. A. Preventive zinc supplementation in developing countries: impact on mortality and morbidity due to diarrhea, pneumonia and malaria. BMC.Public Health 2011;11 Suppl 3:S23. View abstract.
  48. Lassi, Z. S., Haider, B. A., and Bhutta, Z. A. Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months. Cochrane.Database.Syst.Rev. 2010;:CD005978. View abstract.
  49. Simonart, T. and de, Maertelaer, V. Systemic treatments for cutaneous warts: a systematic review. J Dermatolog.Treat. 2012;23:72-77. View abstract.
  50. Chandyo, R. K., Shrestha, P. S., Valentiner-Branth, P., Mathisen, M., Basnet, S., Ulak, M., Adhikari, R. K., Sommerfelt, H., and Strand, T. A. Two weeks of zinc administration to Nepalese children with pneumonia does not reduce the incidence of pneumonia or diarrhea during the next six months. J Nutr 2010;140:1677-1682. View abstract.
  51. Vecchio, M., Navaneethan, S. D., Johnson, D. W., Lucisano, G., Graziano, G., Querques, M., Saglimbene, V., Ruospo, M., Bonifati, C., Jannini, E. A., and Strippoli, G. F. Treatment options for sexual dysfunction in patients with chronic kidney disease: a systematic review of randomized controlled trials. Clin J Am Soc Nephrol. 2010;5:985-995. View abstract.
  52. Baum, M. K., Lai, S., Sales, S., Page, J. B., and Campa, A. Randomized, controlled clinical trial of zinc supplementation to prevent immunological failure in HIV-infected adults. Clin Infect.Dis. 6-15-2010;50:1653-1660. View abstract.
  53. Patel, A., Mamtani, M., Dibley, M. J., Badhoniya, N., and Kulkarni, H. Therapeutic value of zinc supplementation in acute and persistent diarrhea: a systematic review. PLoS.One. 2010;5:e10386. View abstract.
  54. Walker, C. L. and Black, R. E. Zinc for the treatment of diarrhoea: effect on diarrhoea morbidity, mortality and incidence of future episodes. Int J Epidemiol. 2010;39 Suppl 1:i63-i69. View abstract.
  55. Iannotti, L. L., Zavaleta, N., Leon, Z., Huasquiche, C., Shankar, A. H., and Caulfield, L. E. Maternal zinc supplementation reduces diarrheal morbidity in peruvian infants. J Pediatr 2010;156:960-4, 964. View abstract.
  56. Hambidge, K. M., Miller, L. V., Westcott, J. E., Sheng, X., and Krebs, N. F. Zinc bioavailability and homeostasis. Am J Clin Nutr 2010;91:1478S-1483S. View abstract.
  57. Segreto, V. A., Collins, E. M., D'Agostino, R., Cancro, L. P., Pfeifer, H. J., and Gilbert, R. J. Anticalculus effect of a dentifrice containing 0.5% zinc citrate trihydrate. Community Dent.Oral Epidemiol. 1991;19:29-31. View abstract.
  58. Gutierrez, Castrellon P., Polanco, Allue, I, and Salazar, Lindo E. [An evidence based Iberic-Latin American guideline for acute gastroenteritis management in infants and prescholars]. An.Pediatr.(Barc.) 2010;72:220. View abstract.
  59. Christian, P., Stewart, C. P., LeClerq, S. C., Wu, L., Katz, J., West, K. P., Jr., and Khatry, S. K. Antenatal and postnatal iron supplementation and childhood mortality in rural Nepal: a prospective follow-up in a randomized, controlled community trial. Am J Epidemiol. 11-1-2009;170:1127-1136. View abstract.
  60. Brandrup, F., Menne, T., Agren, M. S., Stromberg, H. E., Holst, R., and Frisen, M. A randomized trial of two occlusive dressings in the treatment of leg ulcers. Acta Derm.Venereol 1990;70:231-235. View abstract.
  61. Cereda, E., Gini, A., Pedrolli, C., and Vanotti, A. Disease-specific, versus standard, nutritional support for the treatment of pressure ulcers in institutionalized older adults: a randomized controlled trial. J Am Geriatr.Soc 2009;57:1395-1402. View abstract.
  62. Taneja, S., Bhandari, N., Rongsen-Chandola, T., Mahalanabis, D., Fontaine, O., and Bhan, M. K. Effect of zinc supplementation on morbidity and growth in hospital-born, low-birth-weight infants. Am J Clin Nutr 2009;90:385-391. View abstract.
  63. da Costa, Mdo D., Spitz, M., Bacheschi, L. A., Leite, C. C., Lucato, L. T., and Barbosa, E. R. Wilson's disease: two treatment modalities. Correlations to pretreatment and posttreatment brain MRI. Neuroradiology 2009;51:627-633. View abstract.
  64. Lin, Y. S., Lin, L. C., and Lin, S. W. Effects of zinc supplementation on the survival of patients who received concomitant chemotherapy and radiotherapy for advanced nasopharyngeal carcinoma: follow-up of a double-blind randomized study with subgroup analysis. Laryngoscope 2009;119:1348-1352. View abstract.
  65. Stefani, M., Bottino, G., Fontenelle, E., and Azulay, D. R. [Efficacy comparison between cimetidine and zinc sulphate in the treatment of multiple and recalcitrant warts]. An.Bras.Dermatol. 2009;84:23-29. View abstract.
  66. Veverka, D. V., Wilson, C., Martinez, M. A., Wenger, R., and Tamosuinas, A. Use of zinc supplements to reduce upper respiratory infections in United States Air Force Academy cadets. Complement Ther Clin Pract 2009;15:91-95. View abstract.
  67. Siwek, M., Dudek, D., Paul, I. A., Sowa-Kucma, M., Zieba, A., Popik, P., Pilc, A., and Nowak, G. Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study. J Affect.Disord. 2009;118(1-3):187-195. View abstract.
  68. Sakagami, M., Ikeda, M., Tomita, H., Ikui, A., Aiba, T., Takeda, N., Inokuchi, A., Kurono, Y., Nakashima, M., Shibasaki, Y., and Yotsuya, O. A zinc-containing compound, Polaprezinc, is effective for patients with taste disorders: randomized, double-blind, placebo-controlled, multi-center study. Acta Otolaryngol. 11-26-2008;1-6. View abstract.
  69. Riggio, O., Ariosto, F., Merli, M., Caschera, M., Zullo, A., Balducci, G., Ziparo, V., Pedretti, G., Fiaccadori, F., Bottari, E., and . Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind crossover trial. Dig.Dis.Sci 1991;36:1204-1208. View abstract.
  70. Bellamy, P. G., Jhaj, R., Mussett, A. J., Barker, M. L., Klukowska, M., and White, D. J. Comparison of a stabilized stannous fluoride/sodium hexametaphosphate dentifrice and a zinc citrate dentifrice on plaque formation measured by digital plaque imaging (DPIA) with white light illumination. J Clin Dent. 2008;19:48-54. View abstract.
  71. Fischer Walker, C. L., Black, R. E., and Baqui, A. H. Does age affect the response to zinc therapy for diarrhoea in Bangladeshi infants? J Health Popul.Nutr 2008;26:105-109. View abstract.
  72. Iannotti, L. L., Zavaleta, N., Leon, Z., Shankar, A. H., and Caulfield, L. E. Maternal zinc supplementation and growth in Peruvian infants. Am J Clin Nutr 2008;88:154-160. View abstract.
  73. Lukacik, M., Thomas, R. L., and Aranda, J. V. A meta-analysis of the effects of oral zinc in the treatment of acute and persistent diarrhea. Pediatrics 2008;121:326-336. View abstract.
  74. Abdulhamid, I., Beck, F. W., Millard, S., Chen, X., and Prasad, A. Effect of zinc supplementation on respiratory tract infections in children with cystic fibrosis. Pediatr.Pulmonol. 2008;43:281-287. View abstract.
  75. Arsenault, J. E., Lopez de, Romana D., Penny, M. E., Van Loan, M. D., and Brown, K. H. Additional zinc delivered in a liquid supplement, but not in a fortified porridge, increased fat-free mass accrual among young Peruvian children with mild-to-moderate stunting. J Nutr 2008;138:108-114. View abstract.
  76. Paradiso, Galatioto G., Gravina, G. L., Angelozzi, G., Sacchetti, A., Innominato, P. F., Pace, G., Ranieri, G., and Vicentini, C. May antioxidant therapy improve sperm parameters of men with persistent oligospermia after retrograde embolization for varicocele? World J Urol. 2008;26:97-102. View abstract.
  77. Lin, L. C., Que, J., Lin, K. L., Leung, H. W., Lu, C. L., and Chang, C. H. Effects of zinc supplementation on clinical outcomes in patients receiving radiotherapy for head and neck cancers: a double-blinded randomized study. Int J Radiat.Oncol Biol Phys 2-1-2008;70:368-373. View abstract.
  78. Singh, P. C. and Ballas, S. K. Drugs for preventing red blood cell dehydration in people with sickle cell disease. Cochrane Database.Syst.Rev 2007;:CD003426. View abstract.
  79. Long, K. Z., Rosado, J. L., Montoya, Y., de Lourdes, Solano M., Hertzmark, E., DuPont, H. L., and Santos, J. I. Effect of vitamin A and zinc supplementation on gastrointestinal parasitic infections among Mexican children. Pediatrics 2007;120:e846-e855. View abstract.
  80. Dimitropoulou, P., Nayee, S., Liu, J. F., Demetriou, L., van, Tongeren M., Hepworth, S. J., and Muir, K. R. Dietary zinc intake and brain cancer in adults: a case-control study. Br J Nutr 2008;99:667-673. View abstract.
  81. Varas Lorenzo, M. J., Lopez, Martinez A., Gordillo, Bernal J., and Mundet, Surroca J. [Comparative study of 3 drugs (aceglutamide aluminum, zinc acexamate, and magaldrate) in the long-term maintenance treatment (1 year) of peptic ulcer]. Rev.Esp.Enferm.Dig. 1991;80:91-94. View abstract.
  82. Sharquie, K. E., Khorsheed, A. A., and Al-Nuaimy, A. A. Topical zinc sulphate solution for treatment of viral warts. Saudi.Med.J 2007;28:1418-1421. View abstract.
  83. Roy, S. K., Raqib, R., Khatun, W., Azim, T., Chowdhury, R., Fuchs, G. J., and Sack, D. A. Zinc supplementation in the management of shigellosis in malnourished children in Bangladesh. Eur J Clin Nutr 2008;62:849-855. View abstract.
  84. Tremellen, K., Miari, G., Froiland, D., and Thompson, J. A randomised control trial examining the effect of an antioxidant (Menevit) on pregnancy outcome during IVF-ICSI treatment. Aust.N.Z.J Obstet.Gynaecol. 2007;47:216-221. View abstract.
  85. Berger, M. M., Baines, M., Raffoul, W., Benathan, M., Chiolero, R. L., Reeves, C., Revelly, J. P., Cayeux, M. C., Senechaud, I., and Shenkin, A. Trace element supplementation after major burns modulates antioxidant status and clinical course by way of increased tissue trace element concentrations. Am J Clin Nutr 2007;85:1293-1300. View abstract.
  86. Mahomed, K., Bhutta, Z., and Middleton, P. Zinc supplementation for improving pregnancy and infant outcome. Cochrane.Database.Syst.Rev. 2007;:CD000230. View abstract.
  87. Khattar, J. A., Musharrafieh, U. M., Tamim, H., and Hamadeh, G. N. Topical zinc oxide vs. salicylic acid-lactic acid combination in the treatment of warts. Int J Dermatol. 2007;46:427-430. View abstract.
  88. Yoshida, S., Endo, S., and Tomita, H. A double-blind study of the therapeutic efficacy of zinc gluconate on taste disorder. Auris Nasus Larynx 1991;18:153-161. View abstract.
  89. Sazawal, S., Black, R. E., Ramsan, M., Chwaya, H. M., Dutta, A., Dhingra, U., Stoltzfus, R. J., Othman, M. K., and Kabole, F. M. Effect of zinc supplementation on mortality in children aged 1-48 months: a community-based randomised placebo-controlled trial. Lancet 3-17-2007;369:927-934. View abstract.
  90. Safai-Kutti, S., Selin, E., Larsson, S., Jagenburg, R., Denfors, I., Sten, G., and Kjellmer, I. Zinc therapy in children with cystic fibrosis. Beitr.Infusionsther. 1991;27:104-114. View abstract.
  91. Lu, H., Cai, L., Mu, L. N., Lu, Q. Y., Zhao, J., Cui, Y., Sul, J. H., Zhou, X. F., Ding, B. G., Elashoff, R. M., Marshall, J., Yu, S. Z., Jiang, Q. W., and Zhang, Z. F. Dietary mineral and trace element intake and squamous cell carcinoma of the esophagus in a Chinese population. Nutr Cancer 2006;55:63-70. View abstract.
  92. Carcamo, C., Hooton, T., Weiss, N. S., Gilman, R., Wener, M. H., Chavez, V., Meneses, R., Echevarria, J., Vidal, M., and Holmes, K. K. Randomized controlled trial of zinc supplementation for persistent diarrhea in adults with HIV-1 infection. J Acquir.Immune.Defic.Syndr. 10-1-2006;43:197-201. View abstract.
  93. Kelemen, L. E., Cerhan, J. R., Lim, U., Davis, S., Cozen, W., Schenk, M., Colt, J., Hartge, P., and Ward, M. H. Vegetables, fruit, and antioxidant-related nutrients and risk of non-Hodgkin lymphoma: a National Cancer Institute-Surveillance, Epidemiology, and End Results population-based case-control study. Am J Clin Nutr 2006;83:1401-1410. View abstract.
  94. Green, J. A., Lewin, S. R., Wightman, F., Lee, M., Ravindran, T. S., and Paton, N. I. A randomised controlled trial of oral zinc on the immune response to tuberculosis in HIV-infected patients. Int J Tuberc.Lung Dis. 2005;9:1378-1384. View abstract.
  95. Eby, G. A. and Halcomb, W. W. Ineffectiveness of zinc gluconate nasal spray and zinc orotate lozenges in common-cold treatment: a double-blind, placebo-controlled clinical trial. Altern.Ther.Health Med 2006;12:34-38. View abstract.
  96. Villamor, E., Aboud, S., Koulinska, I. N., Kupka, R., Urassa, W., Chaplin, B., Msamanga, G., and Fawzi, W. W. Zinc supplementation to HIV-1-infected pregnant women: effects on maternal anthropometry, viral load, and early mother-to-child transmission. Eur.J Clin Nutr. 2006;60:862-869. View abstract.
  97. Moran, J., Newcombe, R. G., Wright, P., Haywood, J., Marlow, I., and Addy, M. A study into the plaque-inhibitory activity of experimental toothpaste formulations containing antimicrobial agents. J Clin Periodontol. 2005;32:841-845. View abstract.
  98. Cameron, J., Hoffman, D., Wilson, J., and Cherry, G. Comparison of two peri-wound skin protectants in venous leg ulcers: a randomised controlled trial. J Wound Care 2005;14:233-236. View abstract.
  99. Taneja, S., Bhandari, N., Bahl, R., and Bhan, M. K. Impact of zinc supplementation on mental and psychomotor scores of children aged 12 to 18 months: a randomized, double-blind trial. J Pediatr 2005;146:506-511. View abstract.
  100. Firooz, A., Khatami, A., Khamesipour, A., Nassiri-Kashani, M., Behnia, F., Nilforoushzadeh, M., Pazoki-Toroudi, H., and Dowlati, Y. Intralesional injection of 2% zinc sulfate solution in the treatment of acute old world cutaneous leishmaniasis: a randomized, double-blind, controlled clinical trial. J Drugs Dermatol 2005;4:73-79. View abstract.
  101. Heckmann, S. M., Hujoel, P., Habiger, S., Friess, W., Wichmann, M., Heckmann, J. G., and Hummel, T. Zinc gluconate in the treatment of dysgeusia--a randomized clinical trial. J.Dent.Res. 2005;84:35-38. View abstract.
  102. Weimar, V. M., Puhl, S. C., Smith, W. H., and tenBroeke, J. E. Zinc sulfate in acne vulgaris. Arch.Dermatol. 1978;114:1776-1778. View abstract.
  103. Iraji, F., Vali, A., Asilian, A., Shahtalebi, M. A., and Momeni, A. Z. Comparison of intralesionally injected zinc sulfate with meglumine antimoniate in the treatment of acute cutaneous leishmaniasis. Dermatology 2004;209:46-49. View abstract.
  104. Deng, C., Zheng, B., and She, S. [Clinical study of zinc for the treatment of chronic bacterial prostatitis]. Zhonghua Nan.Ke.Xue. 2004;10:368-370. View abstract.
  105. Nowak, G., Siwek, M., Dudek, D., Zieba, A., and Pilc, A. Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study. Pol.J Pharmacol. 2003;55:1143-1147. View abstract.
  106. Ertekin, M. V., Koc, M., Karslioglu, I., and Sezen, O. Zinc sulfate in the prevention of radiation-induced oropharyngeal mucositis: a prospective, placebo-controlled, randomized study. Int.J.Radiat.Oncol.Biol.Phys. 1-1-2004;58:167-174. View abstract.
  107. McElroy, B. H. and Miller, S. P. An open-label, single-center, phase IV clinical study of the effectiveness of zinc gluconate glycine lozenges (Cold-Eeze) in reducing the duration and symptoms of the common cold in school-aged subjects. Am.J.Ther. 2003;10:324-329. View abstract.
  108. Orbak, R., Cicek, Y., Tezel, A., and Dogru, Y. Effects of zinc treatment in patients with recurrent aphthous stomatitis. Dent.Mater.J. 2003;22:21-29. View abstract.
  109. Arda, H. N., Tuncel, U., Akdogan, O., and Ozluoglu, L. N. The role of zinc in the treatment of tinnitus. Otol.Neurotol. 2003;24:86-89. View abstract.
  110. Sakai, F., Yoshida, S., Endo, S., and Tomita, H. Double-blind, placebo-controlled trial of zinc picolinate for taste disorders. Acta Otolaryngol.Suppl 2002;:129-133. View abstract.
  111. Dreno, B., Moyse, D., Alirezai, M., Amblard, P., Auffret, N., Beylot, C., Bodokh, I., Chivot, M., Daniel, F., Humbert, P., Meynadier, J., and Poli, F. Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris. Dermatology 2001;203:135-140. View abstract.
  112. Shankar, A. H., Genton, B., Baisor, M., Paino, J., Tamja, S., Adiguma, T., Wu, L., Rare, L., Bannon, D., Tielsch, J. M., West, K. P., Jr., and Alpers, M. P. The influence of zinc supplementation on morbidity due to Plasmodium falciparum: a randomized trial in preschool children in Papua New Guinea. Am.J.Trop.Med.Hyg. 2000;62:663-669. View abstract.
  113. Sharquie, K. E., Najim, R. A., Farjou, I. B., and Al Timimi, D. J. Oral zinc sulphate in the treatment of acute cutaneous leishmaniasis. Clin.Exp.Dermatol. 2001;26:21-26. View abstract.
  114. Gupta, R., Garg, V. K., Mathur, D. K., and Goyal, R. K. Oral zinc therapy in diabetic neuropathy. J Assoc.Physicians India 1998;46:939-942. View abstract.
  115. Dutta, P., Mitra, U., Datta, A., Niyogi, S. K., Dutta, S., Manna, B., Basak, M., Mahapatra, T. S., and Bhattacharya, S. K. Impact of zinc supplementation in malnourished children with acute watery diarrhoea. J Trop.Pediatr. 2000;46:259-263. View abstract.
  116. Gueri, M., Van, Devanter S., Serjeant, B. E., and Serjeant, G. R. Oral zinc sulphate treatment of chronic non-sickle cell ulcers in Jamaica. West Indian Med J 1975;24:26-29. View abstract.
  117. Munoz, E. C., Rosado, J. L., Lopez, P., Furr, H. C., and Allen, L. H. Iron and zinc supplementation improves indicators of vitamin A status of Mexican preschoolers. Am.J.Clin.Nutr. 2000;71:789-794. View abstract.
  118. Arad, A., Mimouni, D., Ben Amitai, D., Zeharia, A., and Mimouni, M. Efficacy of topical application of eosin compared with zinc oxide paste and corticosteroid cream for diaper dermatitis. Dermatology 1999;199:319-322. View abstract.
  119. Mocchegiani, E., Muzzioli, M., Gaetti, R., Veccia, S., Viticchi, C., and Scalise, G. Contribution of zinc to reduce CD4+ risk factor for 'severe' infection relapse in aging: parallelism with HIV. Int.J.Immunopharmacol. 1999;21:271-281. View abstract.
  120. Imdad, A., Sadiq, K., and Bhutta, Z. A. Evidence-based prevention of childhood malnutrition. Curr.Opin.Clin.Nutr Metab Care 2011;14:276-285. View abstract.
  121. Luabeya, K. K., Mpontshane, N., Mackay, M., Ward, H., Elson, I., Chhagan, M., Tomkins, A., Van den Broeck, J., and Bennish, M. L. Zinc or multiple micronutrient supplementation to reduce diarrhea and respiratory disease in South African children: a randomized controlled trial. PLoS.One. 2007;2:e541. View abstract.
  122. Bobat, R., Coovadia, H., Stephen, C., Naidoo, K. L., McKerrow, N., Black, R. E., and Moss, W. J. Safety and efficacy of zinc supplementation for children with HIV-1 infection in South Africa: a randomised double-blind placebo-controlled trial. Lancet 11-26-2005;366:1862-1867. View abstract.
  123. Beale, R. J., Sherry, T., Lei, K., Campbell-Stephen, L., McCook, J., Smith, J., Venetz, W., Alteheld, B., Stehle, P., and Schneider, H. Early enteral supplementation with key pharmaconutrients improves Sequential Organ Failure Assessment score in critically ill patients with sepsis: outcome of a randomized, controlled, double-blind trial. Crit Care Med. 2008;36:131-144. View abstract.
  124. Brewer, G. J., Johnson, V., Dick, R. D., Kluin, K. J., Fink, J. K., and Brunberg, J. A. Treatment of Wilson disease with ammonium tetrathiomolybdate. II. Initial therapy in 33 neurologically affected patients and follow-up with zinc therapy. Arch Neurol. 1996;53:1017-1025. View abstract.
  125. Faber, M., Kvalsvig, J. D., Lombard, C. J., and Benade, A. J. Effect of a fortified maize-meal porridge on anemia, micronutrient status, and motor development of infants. Am J Clin Nutr 2005;82:1032-1039. View abstract.
  126. Festa, M. D., Anderson, H. L., Dowdy, R. P., and Ellersieck, M. R. Effect of zinc intake on copper excretion and retention in men. Am J Clin Nutr 1985;41:285-292. View abstract.
  127. Desneves, K. J., Todorovic, B. E., Cassar, A., and Crowe, T. C. Treatment with supplementary arginine, vitamin C and zinc in patients with pressure ulcers: a randomised controlled trial. Clin.Nutr. 2005;24:979-987. View abstract.
  128. Intorre, F., Polito, A., Andriollo-Sanchez, M., Azzini, E., Raguzzini, A., Toti, E., Zaccaria, M., Catasta, G., Meunier, N., Ducros, V., O'Connor, J. M., Coudray, C., Roussel, A. M., and Maiani, G. Effect of zinc supplementation on vitamin status of middle-aged and older European adults: the ZENITH study. Eur.J Clin Nutr 2008;62:1215-1223. View abstract.
  129. Cossack, Z. T. and van den Hamer, C. J. Kinetics of copper absorption in zinc-overload states and following the withdrawal of zinc supplement: the role of endogenous zinc status. J Pediatr Gastroenterol.Nutr 1987;6:296-301. View abstract.
  130. Kimmel, P. Zinc and chronic renal disease. Seminar in Dialysis 1989;2:253-259.
  131. Palomo F, Wantland L, Sanchez A, Volpe AR, McCool J, DeVizio W. The effect of three commercially available dentifrices containing triclosan on supragingival plaque formation and gingivitis: a six month clinical study. Int Dent J. 1994 Feb;44(1 Suppl 1):75-81. View abstract.
  132. Misbahuddin M, Islam A Z, Khandker S, et al. Efficacy of spirulina extract plus zinc in patients of chronic arsenic poisoning: a randomized placebo-controlled study. Clin Toxicol (Phila) 2006;44:135-41. View abstract.
  133. Science M, Johnstone J, Roth DE, et al. Zinc for the treatment of the common cold: a systematic review and meta-analysis of randomized controlled trials. CMAJ 2012;184:E551-61. View abstract.
  134. Nouri M, Chalian H, Bahman A, et al. Nail molybdenum and zinc contents in populations with low and moderate incidence of esophageal cancer. Arch Iranian Med 2008;11:392-6. View abstract.
  135. GlaxoSmithKline Consumer Advisory. GlaxoSmithKline (GSK) warns about a potential health risk associated with long-term, excessive use of GSK's zinc-containing denture adhesives Super Polygrip Original, Ultra Fresh and Extra Care. February 18, 2010. Available at: www.gsk.com/media/consumer-advisories/US.pdf.
  136. Health Canada / GlaxoSmithKline Consumer Healthcare. Association of long-term, excessive use of zinc-containing Poli-Grip products with myeloneuropathy and blood dyscrasias. February 18, 2010. Available at: http://hc-sc.gc.ca/dhp-mps/alt_formats/pdf/medeff/advisories-avis/prof/2010/poligrip_hpc-cps-eng.pdf.
  137. Alexander TH, Davidson TM. Intranasal zinc and anosmia: the zinc-induced anosmia syndrome. Laryngoscope 2006;116:217-20. View abstract.
  138. Dooren JC. FDA warns against use of Zicam. The Wall Street Journal, June 16, 2009. Available at: http://online.wsj.com/article/SB124516778692319231.html#mod=djemHL?mg=com-wsj (Accessed 16 June 2009).
  139. Public Health Advisory. Loss of sense of smell with intranasal cold remedies containing zinc. U.S. Food and Drug Administration, June 16, 2009. Available at: http://www.fda.gov/Drugs/DrugSafety/PublicHealthAdvisories/ucm166059.htm (Accessed 16 June 2009).
  140. Lawson KA, Wright ME, Subar A, et al. Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study. J Natl Cancer Inst 2007;99:754-64. View abstract.
  141. Devereux G, Turner SW, Craig LC, et al. Low maternal vitamin E intake during pregnancy is associated with asthma in 5-year-old children. Am J Respir Crit Care Med 2006;174:499-507. View abstract.
  142. Aggarwal R, Sentz J, Miller MA. Role of zinc administration in prevention of childhood diarrhea and respiratory illnesses: a meta-analysis. Pediatrics 2007;119:1120-30. View abstract.
  143. Hyun TH, Barrett-Connor E, Milne DB. Zinc intakes and plasma concentrations in men with osteoporosis: the Rancho Bernardo Study. Am J Clin Nutr 2004;80:715-21. View abstract.
  144. van Leeuwen R, Boekhoorn S, Vingerling JR, et al. Dietary intake of antioxidants and risk of age-related macular degeneration. JAMA 2005;294:3101-7. View abstract.
  145. Meyer F, Galan P, Douville P, et al. Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial. Int J Cancer 2005;116:182-6. View abstract.
  146. Nechifor M, Vaideanu C, Palamaru I, et al. The influence of some antipsychotics on erythrocyte magnesium and plasma magnesium, calcium, copper and zinc in patients with paranoid schizophrenia. J Am Coll Nutr 2004;23:549S-51S. View abstract.
  147. Nielsen FH, Milne DB. A moderately high intake compared to a low intake of zinc depresses magnesium balance and alters indices of bone turnover in postmenopausal women. Eur J Clin Nutr 2004;58:703-10. View abstract.
  148. Akhondzadeh S, Mohammadi MR, Khademi M. Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children :a double blind and randomized trial. BMC Psychiatry 2004;4:9. View abstract.
  149. Tisdall FF, Brown A, Defries RD. Persistent anosmia following zinc sulfate nasal spraying. JPed 1938;18:60-2.
  150. DeCook CA, Hirsch AR. Anosmia due to inhalational zinc: a case report (abstract). Chem Senses 2000;25:659.
  151. Mayer AD, Rosenblatt JS. Peripheral olfactory deafferentation of the primary olfactory system in rats using ZnSO4 nasal spray with special reference to maternal behavior. Physiol Behav 1993;53:587-92. View abstract.
  152. Ducray A, Bondier JR, Michel G, et al. Recovery following peripheral destruction of olfactory neurons in young and adult mice. Eur J Neurosci 2002;15:1907-17. View abstract.
  153. Burd GD. Morphological study of the effects of intranasal zinc sulfate irrigation on the mouse olfactory epithelium and olfactory bulb. Microsc Res Tech 1993;24:195-213. View abstract.
  154. McBride K, Slotnick B, Margolis FL. Does intranasal application of zinc sulfate produce anosmia in the mouse? An olfactometric and anatomical study. Chem Senses 2003;28:659-70. View abstract.
  155. Moser-Veillon PB. Zinc: consumption patterns and dietary recommendations. J Am Diet Assoc 1990;90:1089-93. View abstract.
  156. Oberleas D, Prasad AS. Factors affecting zinc homeostasis. In: Prasad AS (ed). Trace Elements in Human Health and Disease. Vol 1, zinc and copper. Academic Press, New York, 1976.
  157. Mills CF. Dietary interactions involving the trace elements. Ann Rev Nutr 1985;5:173-93. View abstract.
  158. Hurrell RF. Influence of vegetable protein sources on trace element and mineral bioavailability. J Nutr 2003;133:2973s-7s. View abstract.
  159. Hunt JR. Moving toward a plant-based diet; are iron and zinc at risk? Nutr Rev 2002;60:127-34. View abstract.
  160. Adams CL, Hambridge M, Raboy V, et al. Zinc absorption from a low-phytic acid maize. Am J Clin Nutr 2002;76:556-9. View abstract.
  161. Sandstrom B, Almgren A, Kivisto B, Cederblad A. Effect of protein level and protein source on zinc absorption in humans. J Nutr 1989;119:48-53. View abstract.
  162. Lonnerdal B, Cederblad A, Davidsson L, Sandstrom B. The effect of individual components of soy formula and cows' milk formula on zinc bioavailability. Am J Clin Nutr 1984;40:1064-70. View abstract.
  163. Lonnerdal B. Dietary factors influencing zinc absorption. J Nutr 2000;130:1378s-83s. View abstract.
  164. Gibson RS, Yeudall F, Drost N, et al. Dietary interventions to prevent zinc deficiency. Am J Clin Nutr 1998;68:484s-7s. View abstract.
  165. Guldager B, Jorgensen PJ, Grandjean P. Metal excretion and magnesium retention in patients with intermittent claudication treated with intravenous disodium EDTA. Clin Chem 1996;42:1938-42. View abstract.
  166. Allain P, Mauras Y, Premel-Cabic A, et al. Effects of an EDTA infusion on the urinary elimination of several elements in healthy subjects. Br J Clin Pharmacol 1991;31:347. View abstract.
  167. Palm R, Hallmans G. Zinc and copper metabolism in phenytoin therapy. Epilepsia 1982;23:453-61. View abstract.
  168. Thomas DJ, Chisholm JJ. Lead, zinc, and copper decorporation during calcium disodium ethylenediamine tetraacetate treatment of lead-poisoned children. J Pharmacol Exp Ther 1986;239:829-35. View abstract.
  169. American Academy of Pediatrics Committee on Drugs. Treatment guidelines for lead exposure in children. Pediatrics 1995;96:155-60. View abstract.
  170. Higgins TL, Murray M, Kett DH, et al. Trace element homeostasis during continuous sedation with propofol containing EDTA versus other sedatives in critically ill patients. Intensive Care Med 2000;26:s413-21. View abstract.
  171. Personal communication: Pantoprazole IV - safety and tolerability of EDTA. Medical Information Department, Wyeth Pharmaceuticals Inc., Philadelphia, PA. February 24, 2005.
  172. Pecoud A, Donzel P, Schelling JL. Effect of foodstuffs on the absorption of zinc sulfate. Clin Pharmacol Ther 1975;17:469-74. View abstract.
  173. Liu CS, Wu HM, Kao SH, Wei YH. Serum trace elements, glutathione, copper/zinc superoxide dismutase, and lipid peroxidation in epileptic patients with phenytoin or carbamazepine monotherapy. Clin Neuropharmacol 1998;21:62. View abstract.
  174. Yuen WC, Whiteoak R, Thompson RP. Zinc concentrations in leucocytes of patients receiving antiepileptic drugs. J Clin Pathol 1998;41:553-5. View abstract.
  175. Kaji M, Ito M, Okuno T, et al. Serum copper and zinc levels in epileptic children with valproate treatment. Epilepsia 1992;33:555-7. View abstract.
  176. Ilhan A, Uz E, Kali S, et al. Serum and hair trace element levels in patients with epilepsy and healthy subjects: does the antiepileptic therapy affect the element concentrations of hair? Eur J Neurol 1999;6:705-9. View abstract.
  177. Akram M, Sullivan C, Mack G, Buchannan N. What is the clinical significance of reduced manganese and zinc levels in treated epileptic patients? Med J Australia 1989;15:113. View abstract.
  178. Verrotti A, Basciani F, Trotta D, et al. Serum copper, zinc, selenium, glutathione peroxidase and superoxide dismutase levels in epileptic children before and after 1 year of sodium valproate and carbamazepine therapy. Epilepsy Res 2002;48:71-5. View abstract.
  179. Hurd RW, Wilder BJ, Van Rinsvelt HA. Valproate, birth defects, and zinc (letter). Lancet 1983;1:181. View abstract.
  180. Lerman-Sagie T, Statter M, Szabo G, Lerman P. Effect of valproic acid therapy on zinc metabolism in children with primary epilepsy. Clin Neuropharmacol 1987;10:80-6. View abstract.
  181. Altunbasak S, Biatmakoui F, Baytok V, et al. Serum and hair zinc levels in epileptic children taking valproic acid. Biol Trace Element Res 1997;58;117-25. View abstract.
  182. Lewis-Jones MS, Evans S, Culshaw MA. Cutaneous manifestations of zinc deficiency during treatment with anticonvulsants. BMJ 1985;290:603-4. View abstract.
  183. Fatemi SH, Calabrese JR. Treatment of valproate-induced alopecia (letter). Ann Pharmacother 1995;29;1302. View abstract.
  184. Hurd RW, Van Rinsvelt HA, Wilder BJ, et al. Selenium, zinc, and copper changes with valproic acid: possible relation to drug side effects. Neurology 1984;34:1393-5. View abstract.
  185. Liukko P, Erkkola R, Pakarinen P, et al. Trace elements during 2 years' oral contraception with low-estrogen preparations. Gynecol Obstet Invest 1988;25:113-7. View abstract.
  186. Powell-Beard L, Lei KY, Shenker L. Effect of long-term oral contraceptive therapy before pregnancy on maternal and fetal zinc and copper status. Obstet Gynecol 1987;69:26-32. View abstract.
  187. Chilvers DC, Jones MM, Selby PL, et al. Effects of oral ethinyl oestradiol and norethisterone on plasma copper and zinc complexes in post-menopausal women. Hormone Metab Res 1985;17:532-5. View abstract.
  188. Hinks LJ, Clayton BE, Lloyd RS. Zinc and copper concentrations in leukocytes and erythrocytes in healthy adults and the effect of oral contraceptives. J Clin Pathol 1983;36:1016-21. View abstract.
  189. Vir SC, Love AH. Zinc and copper nutriture of women taking oral contraceptive agents. Am J Clin Nutr 1981;34:1479-83. View abstract.
  190. Webb JL. Nutritional effects of oral contraceptive use: A review. J Reprod Med 1080;25:150. View abstract.
  191. Prema K, Ramalakshmi Ba, Babu S. Serum copper and zinc in hormonal contraceptive users. Fertil Steril 1980;33;267-71. View abstract.
  192. Prasad AS, Oberleas D, Lei KY, et al. Effect of oral contraceptive agents on nutrients: I. Minerals. Am J Clin Nutr 1975;28:377-84. View abstract.
  193. Smith JC, Brown ED. Effects of oral contraceptive agents on trace element metabolism - a review. In: Prasad AS (ed). Trace Elements in Human Health and Disease. Vol.II, Essential and Toxic Elements. New York: Academic Press, 1976. 315-45.
  194. King JC. Do women using oral contraceptive agents require extra zinc? J Nutr 1987;117:217-9. View abstract.
  195. Solecki TJ, Aviv A, Bogden JG. Effect of a chelating drug on balance and tissue distribution of four essential metals. Toxicology 1984;31:207-16. View abstract.
  196. De Palma P, Franco F, Bragliani G, et al. The incidence of optic neuropathy in 84 patients treated with ethambutol. Metab Pediatr Syst Ophthalmol 1989;12:80-2. View abstract.
  197. King AB, Schwartz R. Effects of the antituberculous drug ethambutol on zinc absorption, turnover and distribution in rats fed diets marginal and adequate in zinc. J Nutr 1987;117:704-8. View abstract.
  198. Serfaty-Lacrosniere C, Wood RJ, Voytko D, et al. Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium, or zinc from food in humans. J Am Coll Nutr 1995;14:364-8. View abstract.
  199. Ozutemiz AO, Aydin HH, Isler M, et al. Effect of omeprazole on plasma zinc levels after oral zinc administration. Ind J Gastroenterol 2002;21:216-8. View abstract.
  200. Sturniolo GC, Montino MC, Rossetto L, et al. Inhibition of gastric acid secretion reduces zinc absorption in man. J Am Coll Nutr 1991;10:372. View abstract.
  201. Sorensen JA, Andersen O. Effects of diethyldithiocarbamate and tetrathylthiuram disulfide on zinc metabolism in mice. Pharmacol Toxicol 1989;65:209-13. View abstract.
  202. Leary WP, Reyes AJ, Van der Byl K. Urinary magnesium and zinc excretion after two different single doses of amiloride in healthy adults. Curr Ther Res 1983;34:205-16.
  203. Hasinoff BB. Chemistry of dexrazoxane and analogues. Semin Oncol 1998;24:3-9. View abstract.
  204. Von Hoff DD. Phase I trials of dexrazoxane and other potential applications for the agent. Semin Oncol 1998;25:31-6. View abstract.
  205. Schiliro G, Russo A, Azzia N, et al. Leukocyte alkaline phosphatase (LAP). A useful marker of zinc status in beta-thalassemic patients. Am J Ped Hematol Oncol 1987;9:149-52. View abstract.
  206. Silliman CC, Peterson VM, Mellman DL, et al. Iron chelation by deferoxamine in sickle cell patients with severe transfusion-induced hemosiderosis: a randomized, double-blind study of the dose-response relationship. J Lab Clin Med 1993;122:48-54. View abstract.
  207. Canatan D, Temimhan N, Dincer N, et al. Continuous desferrioxamine infusion by an infusor in thalassemia major. Acta Paediatrica 1999;88:550-2. View abstract.
  208. Pinna A, Corda L, Carta F. Rapid recovery with oral zinc sulphate in deferoxamine-induced presumed optic neuropathy and hearing loss. J Neuroophthalmol 2001;21:32-3. View abstract.
  209. Golik A, Modai D, Weissgarten J, et al. Hydrochlorothiazide-amiloride causes excessive urinary zinc excretion. Clin Pharmacol Ther 1987;42:42-4. View abstract.
  210. Wester PO. Urinary zinc excretion during treatment with different diuretics. Acta Med Scand 1980;208:209-12. View abstract.
  211. Doz F, Berens ME, Deschepper CF, et al. Experimental basis for increasing the therapeutic index of cis-diamminedicarboxylatocyclobutaneplatinum(II) in brain tumor therapy by a high-zinc diet. Cancer Chemother Pharmacol 1992;29:219-26. View abstract.
  212. Kondo Y, Yamagata K, Satoh M, et al. Optimal administration schedule of cisplatin for bladder tumor with minimal induction of metallothionein. J Urol 2003;170:2467-70. View abstract.
  213. Zumkley H, Bertram HP, Preusser P, et al. Renal excretion and magnesium and trace elements during cisplatin treatment. Clin Nephrol 1982;17:254. View abstract.
  214. Sweeney JD, Ziegler P, Pruet C, Spaulding MB. Hyperzincuria and hypozincemia in patients treated with cisplatin. Clin Nephrol 1982;17:254-7. View abstract.
  215. O'Connor DT, Strause L, Saltman P, et al. Serum zinc is unaffected by effective captopril treatment of hypertension. J Clin Hypertens 1987;3:405-8. View abstract.
  216. Zumkley H, Bertram HP, Vetter H, et al. Zinc metabolism during captopril treatment. Horm Metab Res 1985;17;256-8. View abstract.
  217. Smit AJ, Hoorntje SJ, Donker AJ. Zinc deficiency during captopril treatment. Nephron 1983;34:196-7. View abstract.
  218. McNeil JJ, Anderson A, Christophidis N, et al. Taste loss associated with oral captopril treatment. BMJ 1979;448:1555-6. View abstract.
  219. Wise A. Phytate and zinc bioavailability. Int J Food Sci Nutr 1995;46:53-63. View abstract.
  220. Penttila O, Hurme H, Neuvonen PJ. Effect of zinc sulfate on the absorption of tetracycline and doxycycline in man. Eur J Clin Pharmacol 1975;9:131-4. View abstract.
  221. Kingberg WG, Prasad AS, Oberleas D. Zinc deficiency following penicillamine therapy. In: Prasad AS (ed). Trace Elements in Human Health and Disease. Vol.I, Zinc and Copper. Academic Press, New York, 1976. pp51-65.
  222. Weismann K. Chelating drugs and zinc. Dan Med Bull 1986;33:208-11. View abstract.
  223. McCall JT, Goldstein NP, Randall RV, Gross JB. Comparative metabolism of copper and zinc in patients with Wilson's Disease (hepatollenticular degeneration). Am J Med Sci 1967;254:13-23. View abstract.
  224. Flynn A, Pories WJ, Strain WH, et al. Rapid serum zinc depletion associated with corticosteroid therapy. Lancet 1971;2:1169-72. View abstract.
  225. Ellul-Micallef R, Galdes A, Fenech FF. Serum zinc levels in corticosteroid-treated asthmatic patients. Postgrad Med J 1976;52:148-50. View abstract.
  226. Henkin RI, Foster DM, Aamodt RL, Berman M. Zinc metabolism in adrenal cortical insufficiency: effects of carbohydrate-active steroids. Metabolism 1984;33:491-501. View abstract.
  227. Scott R, Ferrie B, McLelland A, Fell GS. The effect of steroid therapy on serum trace metal levels in sub-fertile males. Urol Res 1984;12:213-5. View abstract.
  228. Weismann K, Hoyer H. Serum zinc levels during oral glucocorticoid therapy. J Invest Dermatol 1986;86:715-6. View abstract.
  229. Yunice AA, Czerwinski AW, Lindeman RD. Influence of synthetic corticosteroids on plasma zinc and copper levels in humans. Am J Med Sci 1981;282:68-74. View abstract.
  230. Mery C, Delrieu F, Ghozlan R, et al. Controlled trial of D-penicillamine in rheumatoid arthritis. Dose effect and the role of zinc. Scand J Rheumatol 1976;5:241-7. View abstract.
  231. Abu-Hamdan DK, Mahajan SK, Migdal S, et al. Zinc tolerance test in uremia: effect of calcitriol supplementation. J Am Coll Nutr 1988;7:235-40. View abstract.
  232. Antoniou LD, Shalhoub RJ, Elliot S. Zinc tolerance tests in chronic aremia. Clin Nephrol 1981;16:181-7. View abstract.
  233. Fleet JC, Turnbull AJ, Bourcier M, Wood RJ. Vitamin D-sensitive and quinacrine-sensitive zinc transport in human intestinal cell line Caco-2. Am J Physiol 1993;264:G1037-45. View abstract.
  234. Agte VV, Chiplonkar SA, Gokhale MK. Interaction of riboflavin with zinc bioavailability. Ann NY Acad Sci 1992;669:314-6. View abstract.
  235. Polk RE, Healy DP, Sahai J, et al. Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers. Antimicrob Agents Chemother 1989;33:1841-4. View abstract.
  236. Botash AS, Nasca J, Dubowy R, et al. Zinc-induced copper deficiency in an infant. Am J Dis Child 1992;146:709-11. View abstract.
  237. Wood RJ, Zheng JJ. High dietary calcium intakes reduce zinc absorption and balance in humans. Am J Clin Nutr 1997;65:1803-9. View abstract.
  238. Higashi A, Ikeda T, Matsukura M, Matsuda I. Serum zinc and vitamin E concentrations in handicapped children treated with anticonvulsants. Devel Pharmacol Ther 1982;5:109-13. View abstract.
  239. Bilici M, Yildirim F, Kandil S, et al. Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:181-90.. View abstract.
  240. Age-Related Eye Disease Study Research Group. Potential public health impact of age-related eye disease study results: AREDS report no. 11. Arch Ophthalmol 2003;121:1621-4. View abstract.
  241. Barrett S. Zicam Marketers Sued. United States District Court Western District of Michigan Southern Division, Filed October 14, 2003, Case No. 4:03CV0146.
  242. Uebayashi H, Hatanaka T, Kanemura F, Tonosaki K. Acute anosmia in the mouse: behavioral discrimination among the four basic taste substances. Physiol Behav 2001;72:291-6.. View abstract.
  243. Jafek BW, Linschoten M, Murrow BW. Zicam Induced Anosmia. American Rhinologic Society 49th Annual Fall Scientific Meeting abstract. Orlando, Florida. September 20, 2003. http://app.american-rhinologic.org/programs/2003ARSFallProgram071503.pdf (Accessed 24 November 2003).
  244. OTC Ingredient List. FDA Office of Nonprescription Products. March 2006. Available at: www.fda.gov/cder/Offices/OTC/Ingredient_List_P-Z.pdf.
  245. Fawzi WW, Villamor E, Msamanga GI, et al. Trial of zinc supplements in relation to pregnancy outcomes, hematologic indicators, and T cell counts among HIV-1-infected women in Tanzania. Am J Clin Nutr 2005;81:161-7. View abstract.
  246. Berger MM, Shenkin A, Revelly JP, et al. Copper, selenium, zinc, and thiamine balances during continuous venovenous hemodiafiltration in critically ill patients. Am J Clin Nutr 2004;80:410-6. View abstract.
  247. Brooks WA, Yunus M, Santosham M, et al. Zinc for severe pneumonia in very young children: double-blind placebo-controlled trial. Lancet 2004;363:1683-8. View abstract.
  248. Singh BB, Udani J, Vinjamury Sp, et al. Safety and effectiveness of an L-lysine, zinc, and herbal-based product on the treatment of facial and circumoral herpes. Altern Med Rev 2005;10:123-7. View abstract.
  249. Turk S, Bozfakioglu S, Ecder ST, et al. Effects of zinc supplementation on the immune system and on antibody response to multivalent influenza vaccine in hemodialysis patients. Int J Artif Organs 1998;21:274-278.. View abstract.
  250. McElroy BH, Miller SP. Effectiveness of zinc gluconate glycine lozenges (Cold-Eeze) against the common cold in school-aged subjects: a retrospective chart review. Am J Ther 2002;9:472-5.. View abstract.
  251. Bonham M, O'Connor JM, Alexander HD, et al. Zinc supplementation has no effect on circulating levels of peripheral blood leucocytes and lymphocyte subsets in healthy adult men. Br J Nutr 2003;89:695-703.. View abstract.
  252. Turner RB, Cetnarowski WE. Effect of treatment with zinc gluconate or zinc acetate on experimental and natural colds. Clin Infect Dis 2000;31:1202-8.. View abstract.
  253. Turner RB. The treatment of rhinovirus infections: progress and potential. Antiviral Res 2001;49:1-14.. View abstract.
  254. Takkouche B, Regueira-Mendez C, Garcia-Closas R, et al. Intake of vitamin C and zinc and risk of common cold: a cohort study. Epidemiology 2002;13:38-44.. View abstract.
  255. Krone CA, Wyse EJ, Ely JT. Cadmium in zinc-containing mineral supplements. Int J Food Sci Nutr 2001;52:379-82.. View abstract.
  256. Lopez de Romana D, Lonnerdal B, Brown KH. Absorption of zinc from wheat products fortified with iron and either zinc sulfate or zinc oxide. Am J Clin Nutr 2003;78:279-83.. View abstract.
  257. Leitzmann MF, Stampfer MJ, Wu K, et al. Zinc supplement use and risk of prostate cancer. J Natl Cancer Inst 2003;95:1004-7.. View abstract.
  258. Baqui AH, Black RE, El Arifeen S, et al. Effect of zinc supplementation started during diarrhoea on morbidity and mortality in Bangladeshi children: community randomised trial. BMJ 2002;325:1059-62.. View abstract.
  259. Mossad SB. Effect of zincum gluconicum nasal gel on the duration and symptom severity of the common cold in otherwise healthy adults. QJM 2003;96:35-43. View abstract.
  260. Anon. Zinc Against Plasmodium Study Group. Effect of zinc on the treatment of Plasmodium falciparum malaria in children: a randomized controlled trial. Am J Clin Nutr 2002;76:805-12.. View abstract.
  261. Arnold LE, Votolato NA, Kleykamp D, et al. Does hair zinc predict amphetamine improvement of ADD/hyperactivity? Int J Neurosci 1990;50:103-7.. View abstract.
  262. Toren P, Eldar S, Sela BA, et al. Zinc deficiency in attention-deficit hyperactivity disorder. Biol Psychiatry 1996;40:1308-10. View abstract.
  263. Bekaroglu M, Aslan Y, Gedik Y, et al. Relationships between serum free fatty acids and zinc, and attention deficit hyperactivity disorder: a research note. J Child Psychol Psychiatry 1996;37:225-7.. View abstract.
  264. Cantilena LR, Klaassen CD. The effect of chelating agents on the excretion of endogenous metals. Toxicol Appl Pharmacol 1982;63:344-50. View abstract.
  265. Spencer H, Norris C, Williams D. Inhibitory effects of zinc on magnesium balance and magnesium absorption in man. J Am Coll Nutr 1994;13:479-84.. View abstract.
  266. Mahalanabis D, Chowdhury A, Jana S, et al. Zinc supplementation as adjunct therapy in children with measles accompanies by pneumonia: a double-blind, randomized controlled trial. Am J Clin Nutr 2002;76:604-7.. View abstract.
  267. Solomons NW, Jacob RA. Studies on the bioavailability of zinc in humans: effects of heme and nonheme iron on the absorption of zinc. Am J Clin Nutr 1981;34:475-82.. View abstract.
  268. Donangelo CM, Woodhouse LR, King SM, et al. Supplemental zinc lowers measures of iron status in young women with low iron reserves. J Nutr 2002;132:1860-4.. View abstract.
  269. O'Brien KO, Zavaleta N, Caulfield LE, et al. Influence of prenatal iron and zinc supplements on supplemental iron absorption, red blood cell iron incorporation, and iron status in pregnant Peruvian women. Am J Clin Nutr 1999;69:509-15.. View abstract.
  270. Rossander-Hulten L, Brune M, Sandstrom B, et al. Competitive inhibition of iron absorption by manganese and zinc in humans. Am J Clin Nutr 1991;54:152-6.. View abstract.
  271. Crofton RW, Gvozdanovic D, Gvozdanovic S, et al. Inorganic zinc and the intestinal absorption of ferrous iron. Am J Clin Nutr 1989;50:141-4.. View abstract.
  272. Valberg LS, Flanagan PR, Chamberlain MJ. Effects of iron, tin, and copper on zinc absorption in humans. Am J Clin Nutr 1984;40:536-41.. View abstract.
  273. Watkins DW, Khalafi R, Cassidy MM, Vahouny GV. Alterations in calcium, magnesium, iron, and zinc metabolism by dietary cholestyramine. Dig Dis Sci 1985;30:477-82.. View abstract.
  274. Tyrer LB. Nutrition and the pill. J Reprod Med 1984;29:547-50.. View abstract.
  275. Keating JN, Wada L, Stokstad ELR, King JC. Folic acid: effect on zinc absorption in humans and in the rat. Am J Clin Nutr 1987;46:835-9. View abstract.
  276. Kauwell GPA, Baily LB, Gregory JF, et al. Zinc status is not adversely affected by folic acid supplementation and zinc intake does not impair folate utilization in human subjects. J Nutr 1995;125:66-72. View abstract.
  277. Fuller NJ, Bates CJ, Evans PH, Lucas A. High folate intakes related to zinc status in preterm infants. Eur J Pediatr 1992;151:51-3. View abstract.
  278. Butterworth CE, Hatch K, Cole P, et al. Zinc concentration in plasma and erythrocytes of subjects receiving folic acid supplementation. Am J Clin Nutr 1988;47:484-6. View abstract.
  279. Kakar F, Henderson MM. Potential toxic side effects of folic acid (letter). J Natl Cancer Inst 1985;74:263. View abstract.
  280. Milne DB, Canfield WK, Mahalko JR, Sandstead HH. Effect of oral folic acid supplements on zinc, copper, and iron absorption and excretion. Am J Clin Nutr 1984;39:535-9. View abstract.
  281. Wong WY, Merkus HM, Thomas CM, et al. Effects of folic acid and zinc sulfate on male factor subfertility: a double-blind, randomized, placebo-controlled trial. Fertil Steril 2002;77:491-8.. View abstract.
  282. Girodon F, Lombard M, Galan P, et al. Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial. Ann Nutr Metab 1997;41:98-107. View abstract.
  283. Sazawal S, Black RE, Menon VP, et al. Zinc supplementation in infants born small for gestational age reduces mortality: a prospective, randomized, controlled trial. Pediatrics 2001;108:1280-6. View abstract.
  284. Davidsson L, Almgren A, Sandstrom B, Hurrell RF. Zinc absorption in adult humans: the effect of iron fortification. Br J Nutr 1995;74:417-25.. View abstract.
  285. O'Brien KO, Zavaleta N, Caulfield LE, et al. Prenatal iron supplements impair zinc absorption in pregnant Peruvian women. J Nutr 2000 130:2251-5.. View abstract.
  286. Muller O, Becher H, van Zweeden AB, et al. Effect of zinc supplementation on malaria and other causes of morbidity in west African children: randomised double blind placebo controlled trial. BMJ 2001;322:1567. View abstract.
  287. Bhandari N, Bahl R, Taneja S, et al. Effect of routine zinc supplementation on pneumonia in children aged 6 months to 3 years: randomised controlled trial in an urban slum. BMJ 2002;324:1358. View abstract.
  288. Rahman MM, Wahed MA, Fuchs GJ, et al. Synergistic effect of zinc and vitamin A on the biochemical indexes of vitamin A nutrition in children. Am J Clin Nutr 2002;75:92-8. View abstract.
  289. Bhutta ZA, Bird SM, Black RE, et al. Therapeutic effects of oral zinc in acute and persistent diarrhea in children in developing countries: pooled analysis of randomized controlled trials. Am J Clin Nutr 2000;72:1516-22. View abstract.
  290. King JC. Enhanced zinc utilization during lactation may reduce maternal and infant zinc depletion. Am J Clin Nutr 2002;75:2-3. View abstract.
  291. Sian L, Krebs NF, Westcott JE, et al. Zinc homeostasis during lactation in a population with a low zinc intake. Am J Clin Nutr 2002;75:99-103. View abstract.
  292. Christian P, Khatry SK, Yamini S, et al. Zinc supplementation might potentiate the effect of vitamin A in restoring night vision in pregnant Nepalese women. Am J Clin Nutr 2001;73:1045-51. View abstract.
  293. Belongia EA, Berg R, Liu K. A randomized trial of zinc nasal spray for the treatment of upper respiratory illness in adults. Am J Med 2001;111:103-8. View abstract.
  294. Turner RB. Ineffectiveness of intranasal zinc gluconate for prevention of experimental rhinovirus colds. Clin Infect Dis 2001;33:1865-70. View abstract.
  295. Prasad AS. Zinc deficiency in patients with sickle cell disease. Am J Clin Nutr 2002;75:181-2. View abstract.
  296. Zemel BS, Kawchak DA, Fung EB, et al. Effect of zinc supplementation on growth and body composition in children with sickle cell disease. Am J Clin Nutr 2002;75:300-7. View abstract.
  297. Siberry GK, Ruff AJ, Black R. Zinc and human immunodeficiency virus infection. Nutr Res 2002;22:527-38.
  298. Bianchi GP, Marchesini G, Brizi M, et al. Nutritional effects of oral zinc supplementation in cirrhosis. Nutr Res 2000;20:1079-89.
  299. Godfrey HR, Godfrey NJ, Godfrey JC, Riley D. A randomized clinical trial on the treatment of oral herpes with topical zinc oxide/glycine. Altern Ther Health Med 2001;7:49-56. View abstract.
  300. The Age-Related Eye Disease Study (AREDS) Research Group. The effect of five-year zinc supplementation on serum zinc, serum cholesterol and hematocrit in persons randomly assigned to treatment group in the age-related eye disease study: AREDS Report No. 7. J Nutr 2002;132:697-702. View abstract.
  301. Grahn BH, Paterson PG, Gottschall-Pass KT, Zhang Z. Zinc and the eye. J Am Coll Nutr 2001;20:106-18. View abstract.
  302. Tang X, Shay NF. Zinc has an insulin-like effect on glucose transport mediated by phosphoinositol-3-kinase and Akt in 3T3-L1 fibroblasts and adipocytes. J Nutr 2001;131:1414-20. View abstract.
  303. Freake HC, Govoni KE, Guda K, et al. Actions and interactions of thyroid hormone and zinc status in growing rats. J Nutr 2001;4:1135-41.. View abstract.
  304. Greenberg JE, Lynn M, Kirsner RS, et al. Mucocutaneous pigmented macule as a result of zinc deposition. J Cutan Pathol 2002;29:613-5. View abstract.
  305. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academy Press, 1999. Available at: http://books.nap.edu/books/0309063507/html/index.html.
  306. Whittaker P. Iron and zinc interactions in humans. Am J Clin Nutr 1998;68:442S-6S. View abstract.
  307. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol 2001;119:1439-52. View abstract.
  308. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. AREDS report no. 8. Arch Ophthalmol 2001;119:1417-36. View abstract.
  309. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academy Press, 2002. Available at: www.nap.edu/books/0309072794/html/.
  310. Camacho FM, Garcia-Hernandez MJ. Zinc aspartate, biotin, and clobetasol propionate in the treatment of alopecia areata in childhood. Pediatr Dermatol 1999;16:336-8. View abstract.
  311. Ead RD. Oral zinc sulphate in alopacia areata- a double-blind trial. Br J Dermatol 1981;104:483-4. View abstract.
  312. Paaske PB, Pedersen CB, Kjems G, Sam IL. Zinc in the management of tinnitus. Placebo-controlled trial. Ann Otol Rhinol Laryngol 1991;100:647-9. View abstract.
  313. Atik OS. Zinc and senile osteoporosis. J Am Geriatr Soc 1983;31:790-1. View abstract.
  314. Relea P, Revilla M, Ripoll E, et al. Zinc, biochemical markers of nutrition, and type I osteoporosis. Age Ageing 1995;24:303-7. View abstract.
  315. Naber TH, van den Hamer CJ, Baadenhuysen H, Jansen JB. The value of methods to determine zinc deficiency in patients with Crohn's disease. Scand J Gastroenterol 1998;33:514-23. View abstract.
  316. Dronfield MW, Malone JD, Langman MJ. Zinc in ulcerative colitis: a therapeutic trial and report on plasma levels. Gut 1977;18:33-6. View abstract.
  317. van de Wal Y, van der Sluys Veer A, Verspaget HW, et al. Effect of zinc therapy on natural killer cell activity in inflammatory bowel disease. Aliment Pharmacol Ther 1993;7:281-6. View abstract.
  318. Sjogren A, Floren CH, Nilsson A. Evaluation of zinc status in subjects with Crohn's disease. J Am Coll Nutr 1988;7:57-60. View abstract.
  319. Mulder TP, van der Sluys Veer A, Verspaget HW, et al. Effect of oral zinc supplementation on metallothionein and superoxide dismutase concentrations in patients with inflammatory bowel disease. J Gastroenterol Hepatol 1994;9:472-7. View abstract.
  320. David TJ, Wells FE, Sharpe TC, et al. Serum levels of trace metals in children with atopic eczema. Br J Dermatol 1990;122:485-9. View abstract.
  321. Ewing CI, Gibbs AC, Ashcroft C, David TJ. Failure of oral zinc supplementation in atopic eczema. Eur J Clin Nutr 1991;45:507-10. View abstract.
  322. Zaichick VY, Sviridova TV, Zaichick SV. Zinc concentration in human prostatic fluid: normal, chronic prostatitis, adenoma and cancer. Int Urol Nephrol 1996;28:687-94. View abstract.
  323. Zaichick VYe, Sviridova TV, Zaichick SV. Zinc in the human prostate gland: normal, hyperplastic and cancerous. Int Urol Nephrol 1997;29:565-74. View abstract.
  324. Lagiou P, Wuu J, Trichopoulou A, et al. Diet and benign prostatic hyperplasia: a study in Greece. Urology 1999;54:284-90. View abstract.
  325. Katz RL, Keen CL, Litt IF, et al. Zinc deficiency in anorexia nervosa. J Adolesc Health Care 1987;8:400-6. View abstract.
  326. Birmingham CL, Goldner EM, Bakan R. Controlled trial of zinc supplementation in anorexia nervosa. Int J Eat Disord 1994;15:251-5. View abstract.
  327. Sandstrom B, Kivisto B, Cederblad A. Absorption of zinc from soy protein meals in humans. J Nutr 1987;117:321-7. View abstract.
  328. Wilkinson EA, Hawke CI. Oral zinc for arterial and venous leg ulcers. Cochrane Database Syst Rev 2000;2:CD001273. View abstract.
  329. Stromberg HE, Agren MS. Topical zinc oxide treatment improves arterial and venous leg ulcers. Br J Dermatol 1984;111:461-8. View abstract.
  330. Antoniou LD, Shalhoub RJ, Sudhakar T, Smith JC Jr. Reversal of uraemic impotence by zinc. Lancet 1977;2:895-8. View abstract.
  331. Desbiens NA. Lessons learned from attempts to establish the blind in placebo-controlled trials of zinc for the common cold. Ann Intern Med 2000;133:302-3. View abstract.
  332. Petrus EJ, Lawson KA, Bucci LR, Blum K. Randomized, double-masked, placebo-controlled clinical study of the effectiveness of zinc acetate lozenges on common cold symptoms in allergy-tested subjects. Curr Ther Res 1998;59:595-607.
  333. Prasad AS, Fitzgerald JT, Bao B, et al. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2000;133:245-52. View abstract.
  334. Douglas RM, Miles HB, Moore BW, et al. Failure of effervescent zinc acetate lozenges to alter the course of upper respiratory tract infections in Australian adults. Antimicrob Agents Chemother 1987;31:1263-5. View abstract.
  335. Benso L, Gambotto S, Pastorin L, et al. Growth velocity monitoring of the efficacy of different therapeutic protocols in a group of thalassaemic children. Eur J Pediatr 1995;154:205-8. View abstract.
  336. Uysal Z, Akar N, Kemahli S, et al. Desferrioxamine and urinary zinc excretion in beta-thalassemia major. Pediatr Hematol Oncol 1993;10:257-60. View abstract.
  337. Aydinok Y, Coker C, Kavakli K, et al. Urinary zinc excretion and zinc status of patients with beta-thalassemia major. Biol Trace Elem Res 1999;70:165-72. View abstract.
  338. Prasad AS, Beck FW, Kaplan J, et al. Effect of zinc supplementation on incidence of infections and hospital admissions in sickle cell disease (SCD). Am J Hematol 1999;61:194-202. View abstract.
  339. Leonard MB, Zemel BS, Kawchak DA, et al. Plasma zinc status, growth, and maturation in children with sickle cell disease. J Pediatr 1998;132:467-71. View abstract.
  340. Gupta VL, Chaubey BS. Efficacy of zinc therapy in prevention of crisis in sickle cell anemia: a double blind, randomized controlled clinical trial. J Assoc Physicians India 1995;43:467-9. View abstract.
  341. Merchant HW, Gangarosa LP, Glassman AB, Sobel RE. Zinc sulfate supplementation for treatment of recurring oral ulcers. South Med J 1977;70:559-61. View abstract.
  342. Wray D. A double-blind trial of systemic zinc sulfate in recurrent aphthous stomatitis. Oral Surg Oral Med Oral Pathol 1982;53:469-72. View abstract.
  343. Frommer DJ. The healing of gastric ulcers by zinc sulphate. Med J Aust 1975;2:793-6. View abstract.
  344. Garcia-Plaza A, Arenas JI, Belda O, Diago A, et al. [A multicenter, clinical trial. Zinc acexamate vs famotidine in the treatment of acute duodenal ulcer. Study group of zinc acexamate]. Rev Esp Enferm Dig 1996;88:757-62. View abstract.
  345. Jimenez E, Bosch F, Galmes JL, Banos JE. Meta-analysis of efficacy of zinc acexamate in peptic ulcer. Digestion 1992;51:18-26. View abstract.
  346. Rodriguez de la Serna A, Diaz-Rubio M. Multicenter clinical trial of zinc acexamate in the prevention of nonsteroidal antiinflammatory drug induced gastroenteropathy. Spanish Study Group on NSAID Induced Gastroenteropathy Prevention. J Rheumatol 1994;21:927-33. View abstract.
  347. Sharquie KE, Najim RA, Farjou IB. A comparative controlled trial of intralesionally-administered zinc sulphate, hypertonic sodium chloride and pentavalent antimony compound against acute cutaneous leishmaniasis. Clin Exp Dermatol 1997;22:169-73. View abstract.
  348. Grazioso CF, Isalgue M, de Ramirez I, et al. The effect of zinc supplementation on parasitic reinfestation of Guatemalan schoolchildren. Am J Clin Nutr 1993;57:673-8. View abstract.
  349. Stur M, Tittl M, Reitner A, Meisinger V. Oral zinc and the second eye in age-related macular degeneration. Invest Ophthalmol Vis Sci 1996;37:1225-35. View abstract.
  350. Newsome DA, Swartz M, Leone NC, et al. Oral zinc in macular degeneration. Arch Ophthalmol 1988;106:192-8. View abstract.
  351. Smith W, Mitchell P, Webb K, Leeder SR. Dietary antioxidants and age-related maculopathy: the Blue Mountains Eye Study. Ophthalmology 1999;106:761-77. View abstract.
  352. Mares-Perlman JA, Klein R, Klein BE, et al. Association of zinc and antioxidant nutrients with age-related maculopathy. Arch Ophthalmol 1996;114:991-7. View abstract.
  353. Omu AE, Dashti H, Al-Othman S. Treatment of asthenozoospermia with zinc sulphate: andrological, immunological and obstetric outcome. Eur J Obstet Gynecol Reprod Biol 1998;79:179-84. View abstract.
  354. Mohan H, Verma J, Singh I, et al. Inter-relationship of zinc levels in serum and semen in oligospermic infertile patients and fertile males. Indian J Pathol Microbiol 1997;40:451-5. View abstract.
  355. Hunt CD, Johnson PE, Herbel J, Mullen LK. Effects of dietary zinc depletion on seminal volume and zinc loss, serum testosterone concentrations, and sperm morphology in young men. Am J Clin Nutr 1992;56:148-57. View abstract.
  356. Chia SE, Ong CN, Chua LH, et al. Comparison of zinc concentrations in blood and seminal plasma and the various sperm parameters between fertile and infertile men. J Androl 2000;21:53-7. View abstract.
  357. Henkel R, Bittner J, Weber R, et al. Relevance of zinc in human sperm flagella and its relation to motility. Fertil Steril 1999;71:1138-43. View abstract.
  358. Fuse H, Kazama T, Ohta S, Fujiuchi Y. Relationship between zinc concentrations in seminal plasma and various sperm parameters. Int Urol Nephrol 1999;31:401-8. View abstract.
  359. Rodger RS, Sheldon WL, Watson MJ, et al. Zinc deficiency and hyperprolactinaemia are not reversible causes of sexual dysfunction in uraemia. Nephrol Dial Transplant 1989;4:888-92. View abstract.
  360. Mahajan SK, Abbasi AA, Prasad AS, et al. Effect of oral zinc therapy on gonadal function in hemodialysis patients. A double-blind study. Ann Intern Med 1982;97:357-61. View abstract.
  361. Khedun SM, Naicker T, Maharaj B. Zinc, hydrochlorothiazide and sexual dysfunction. Cent Afr J Med 1995;41:312-5. View abstract.
  362. Goldiner WH, Hamilton BP, Hyman PD, Russell RM. Effect of the administration of zinc sulfate on hypogonadism and impotence in patients with chronic stable hepatic cirrhosis. J Am Coll Nutr 1983;2:157-62. View abstract.
  363. Brook AC, Johnston DG, Ward MK, et al. Absence of a therapeutic effect of zinc in the sexual dysfunction of haemodialysed patients Lancet 1980;2:618-20. View abstract.
  364. Mocchegiani E, Veccia S, Ancarani F, et al. Benefit of oral zinc supplementation as an adjunct to zidovudine (AZT) therapy against opportunistic infections in AIDS. Int J Immunopharmacol 1995;17:719-27. View abstract.
  365. Tang AM, Graham NM, Saah AJ. Effects of micronutrient intake on survival in human immunodeficiency virus type 1 infection. Am J Epidemiol 1996;143:1244-56. View abstract.
  366. Kelly P, Musonda R, Kafwembe E, et al. Micronutrient supplementation in the AIDS diarrhea-wasting syndrome in Zambia: a randomized controlled trial. AIDS 1999;13:495-500. View abstract.
  367. Provinciali M, Montenovo A, Di Stefano G, et al. Effect of zinc or zinc plus arginine supplementation on antibody titre and lymphocyte subsets after influenza vaccination in elderly subjects: a randomized controlled trial. Age Ageing 1998;27:715-22. View abstract.
  368. Maes M, De Vos N, Demedts P, et al. Lower serum zinc in major depression in relation to changes in serum acute phase proteins. J Affect Disord 1999;56:189-94. View abstract.
  369. Bjorksten B, Back O, Gustavson KH, et al. Zinc and immune function in Down's syndrome. Acta Paediatr Scand 1980;69:183-7. View abstract.
  370. Girodon F, Galan P, Monget AL, et al. Impact of trace elements and vitamin supplementation on immunity and infections in institutionalized elderly patients: a randomized, controlled trial. MIN. VIT. AOX. geriatric network. Arch Intern Med 1999;159:748-54. View abstract.
  371. Prasad AS. Zinc and immunity. Mol Cell Biochem 1998;188:63-9. View abstract.
  372. Shankar AH, Prasad AS. Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr 1998;68:447S-63S. View abstract.
  373. Sprenger KB, Bundschu D, Lewis K, et al. Improvement of uremic neuropathy and hypogeusia by dialysate zinc supplementation: a double-blind study. Kidney Int Suppl 1983;16:S315-8. View abstract.
  374. Watson AR, Stuart A, Wells FE, et al. Zinc supplementation and its effect on taste acuity in children with chronic renal failure. Hum Nutr Clin Nutr 1983;37:219-25. View abstract.
  375. Mahajan SK, Prasad AS, Lambujon J, et al. Improvement of uremic hypogeusia by zinc: a double-blind study. Am J Clin Nutr 1980;33:1517-21. View abstract.
  376. Ripamonti C, Zecca E, Brunelli C, et al. A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation. Cancer 1998;82:1938-45. View abstract.
  377. Henkin RI, Schecter PJ, Friedewald WT, et al. A double-blind study of the effects of zinc sulfate on taste and smell dysfunction. Am J Med Sci 1976;272:285-99. View abstract.
  378. Henkin RI, Martin BM, Agarwal RP. Decreased parotid saliva gustin/carbonic anhydrase VI secretion: an enzyme disorder manifested by gustatory and olfactory dysfunction. Am J Med Sci 1999;318:380-91. View abstract.
  379. Henkin RI, Martin BM, Agarwal RP. Efficacy of exogenous oral zinc in treatment of patients with carbonic anhydrase VI deficiency. Am J Med Sci 1999;318:392-405. View abstract.
  380. Abu-Hamdan DK, Desai H, Sondheimer J, et al. Taste acuity and zinc metabolism in captopril-treated hypertensive male patients. Am J Hypertens 1988;1:303S-8S. View abstract.
  381. Heyneman CA. Zinc deficiency and taste disorders. Ann Pharmacother 1996;30:186-7. View abstract.
  382. Arens M, Travis S. Zinc salts inactivate clinical isolates of herpes simplex virus in vitro. J Clin Microbiol 2000;38:1758-62. View abstract.
  383. Kneist W, Hempel B, Borelli S. [Clinical, double-blind trial of topical zinc sulfate for herpes labialis recidivans]. Arzneimittelforschung 1995;45:624-6. View abstract.
  384. Eby GA, Halcomb WW. Use of topical zinc to prevent recurrent herpes simplex infection: review of literature and suggested protocols. Med Hypotheses 1985;17:157-65. View abstract.
  385. Brody I. Topical treatment of recurrent herpes simplex and post-herpetic erythema multiforme with low concentrations of zinc sulphate solution. Br J Dermatol 1981;104:191-4. View abstract.
  386. George J, Bhatia VN, Balakrishnan S, Ramu G. Serum zinc/copper ratio in subtypes of leprosy and effect of oral zinc therapy on reactional states. Int J Lepr Other Mycobact Dis 1991;59:20-4. View abstract.
  387. Mathur NK, Bumb RA, Mangal HN, Sharma ML. Oral zinc as an adjunct to dapsone in lepromatous leprosy. Int J Lepr Other Mycobact Dis 1984;52:331-8. View abstract.
  388. Mathur NK, Bumb RA, Mangal HN. Oral zinc in recurrent Erythema Nodosum Leprosum reaction. Lepr India 1983;55:547-52. View abstract.
  389. Mahajan PM, Jadhav VH, Patki AH, et al. Oral zinc therapy in recurrent erythema nodosum leprosum: a clinical study. Indian J Lepr 1994;66:51-7. View abstract.
  390. Faure P, Benhamou PY, Perard A, et al. Lipid peroxidation in insulin-dependent diabetic patients with early retina degenerative lesions: effects of an oral zinc supplementation. Eur J Clin Nutr 1995;49:282-8. View abstract.
  391. Blostein-Fujii A, DiSilvestro RA, Frid D, et al. Short-term zinc supplementation in women with non-insulin-dependent diabetes mellitus: effects on plasma 5'-nucleotidase activities, insulin-like growth factor I concentrations, and lipoprotein oxidation rates in vitro. Am J Clin Nutr 1997;66:639-42. View abstract.
  392. Rauscher AM, Fairweather-Tait SJ, Wilson PD, et al. Zinc metabolism in non-insulin dependent diabetes mellitus. J Trace Elem Med Biol 1997;11:65-70. View abstract.
  393. Polenik P. Zinc in etiology of periodontal disease. Med Hypotheses 1993;40:182-5. View abstract.
  394. Williams C, McBride S, Mostler K, et al. Efficacy of a dentifrice containing zinc citrate for the control of plaque and gingivitis: a 6-month clinical study in adults. Compend Contin Educ Dent 1998;19:4-15. View abstract.
  395. Svatun B, Saxton CA, Huntington E, Cummins D. The effects of a silica dentifrice containing Triclosan and zinc citrate on supragingival plaque and calculus formation and the control of gingivitis. Int Dent J 1993;43:431-9. View abstract.
  396. Svatun B, Saxton CA, Rolla G. Six-month study of the effect of a dentifrice containing zinc citrate and triclosan on plaque, gingival health, and calculus. Scand J Dent Res 1990;98:301-4. View abstract.
  397. Stephen KW, Saxton CA, Jones CL, et al. Control of gingivitis and calculus by a dentifrice containing a zinc salt and triclosan. J Periodontol 1990;61:674-9. View abstract.
  398. Schaeken MJ, van der Hoeven JS, Saxton CA, Cummins D. The effect of mouthrinses containing zinc and triclosan on plaque accumulation, development of gingivitis and formation of calculus in a 28-week clinical test. J Clin Periodontol 1996;23:465-70. View abstract.
  399. Guide to Clinical Preventive Services. 2nd ed. Natl Institute of Health, 1996. Available at: http://hstat2.nlm.nih.gov/download/409812772438.html.
  400. Jackson JL, Lesho E, Peterson C. Zinc and the common cold: a meta-analysis revisited. J Nutr 2000;130:1512S-5S. View abstract.
  401. Marshall I. Zinc for the common cold. Cochrane Database Syst Rev 2000;:CD001364. View abstract.
  402. Berger MM, Spertini F, Shenkin A, et al. Trace element supplementation modulates pulmonary infection rates after major burns: a double-blind, placebo-controlled trial. Am J Clin Nutr 1998;68:365-71. View abstract.
  403. Simkin PA. Oral zinc sulphate in rheumatoid arthritis. Lancet 1976;2:539-42. View abstract.
  404. Zoli A, Altomonte L, Caricchio R, et al. Serum zinc and copper in active rheumatoid arthritis: correlation with interleukin 1 beta and tumour necrosis factor alpha. Clin Rheumatol 1998;17:378-82. View abstract.
  405. Rasker JJ, Kardaun SH. Lack of beneficial effect of zinc sulphate in rheumatoid arthritis. Scand J Rheumatol 1982;11:168-70. View abstract.
  406. Dixon JS, Bird HA, Martin MF, et al. Biochemical and clinical changes occurring during the treatment of rheumatoid arthritis with novel antirheumatoid drugs. Int J Clin Pharmacol Res 1985;5:25-33. View abstract.
  407. Clemmensen OJ, Siggaard-Andersen J, Worm AM, et al. Psoriatic arthritis treated with oral zinc sulphate. Br J Dermatol 1980;103:411-5. View abstract.
  408. Leibovici V, Statter M, Weinrauch L, et al. Effect of zinc therapy on neutrophil chemotaxis in psoriasis. Isr J Med Sci 1990;26:306-9. View abstract.
  409. Burrows NP, Turnbull AJ, Punchard NA, et al. A trial of oral zinc supplementation in psoriasis. Cutis 1994;54:117-8. View abstract.
  410. Lovell MA, Xie C, Markesbery WR. Protection against amyloid beta peptide toxicity by zinc. Brain Res 1999;823:88-95. View abstract.
  411. Lovell MA, Robertson JD, Teesdale WJ, et al. Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 1998;158:47-52. View abstract.
  412. Huang X, Cuajungco MP, Atwood CS, et al. Alzheimer's disease, beta-amyloid protein and zinc. J Nutr 2000;130:1488S-92S. View abstract.
  413. Michaelsson G, Ljunghall K. Patients with dermatitis herpetiformis, acne, psoriasis and Darier's disease have low epidermal zinc concentrations. Acta Derm Venereol 1990;70:304-8. View abstract.
  414. Michaelsson G, Vahlquist A, Juhlin L. Serum zinc and retinol-binding protein in acne. Br J Dermatol 1977;96:283-6. View abstract.
  415. Amer M, Bahgat MR, Tosson Z, et al. Serum zinc in acne vulgaris. Int J Dermatol 1982;21:481-4. View abstract.
  416. Michaelsson G, Juhlin L, Ljunghall K. A double-blind study of the effect of zinc and oxytetracycline in acne vulgaris. Br J Dermatol 1977;97:561-6. View abstract.
  417. Cunliffe WJ, Burke B, Dodman B, Gould DJ. A double-blind trial of a zinc sulphate/citrate complex and tetracycline in the treatment of acne vulgaris. Br J Dermatol 1979;101:321-5. View abstract.
  418. Weismann K, Wadskov S, Sondergaard J. Oral zinc sulphate therapy for acne vulgaris. Acta Derm Venereol 1977;57:357-60. View abstract.
  419. Orris L, Shalita AR, Sibulkin D, et al. Oral zinc therapy of acne. Absorption and clinical effect. Arch Dermatol 1978;114:1018-20. View abstract.
  420. Dreno B, Amblard P, Agache P, et al. Low doses of zinc gluconate for inflammatory acne. Acta Derm Venereol 1989;69:541-3. View abstract.
  421. Michaelsson G, Juhlin L, Vahlquist A. Effects of oral zinc and vitamin A in acne. Arch Dermatol 1977;113:31-6. View abstract.
  422. Hirt M, Nobel S, Barron E. Zinc nasal gel for the treatment of common cold symptoms: A double-blind, placebo-controlled trial. Ear Nose Throat J 2000;79:778-82.. View abstract.
  423. Meynadier J. Efficacy and safety study of two zinc gluconate regimens in the treatment of inflammatory acne. Eur J Dermatol 2000 May;10:269-73. View abstract.
  424. Hillstrom L, Pettersson L, Hellbe L, et al. Comparison of oral treatment with zinc sulphate and placebo in acne vulgaris. Br J Dermatol 1977;97:681-4. View abstract.
  425. Goransson K, Liden S, Odsell L. Oral zinc in acne vulgaris: a clinical and methodological study. Acta Derm Venereol 1978;58:443-8. View abstract.
  426. Khanna VJ, Shieh S, Benjamin J, et al. Necrolytic acral erythema associated with hepatitis C effective treatment with interferon alfa and zinc. Arch Dermatol 2000;136:755-7. View abstract.
  427. Traikovich SS. Use of topical ascorbic acid and its effects on photodamaged skin topography. Arch Otolaryngol Head Neck Surg 1999;125:1091-8. View abstract.
  428. Zavaleta N, Caulfield LE, Garcia T. Changes in iron status during pregnancy in peruvian women receiving prenatal iron and folic acid supplements with or without zinc. Am J Clin Nutr 2000;71:956-61. View abstract.
  429. Green S. Chelation therapy: unproven claims and unsound theories. Quackwatch 2000. Available at: http://www.quackwatch.org (Accessed 17 November 2000).
  430. Neuvonen PJ. Interactions with the absorption of tetracyclines. Drugs 1976;11:45-54.. View abstract.
  431. Seelig MS. Auto-immune complications of D-penicillamine - A possible result of zinc and magnesium depletion and of pyridoxine inactivation. J Am Coll Nutr 1982;1:207-14. View abstract.
  432. Segal S, Kaminski S. Drug-nutrient interactions. American Druggist 1996 Jul;42-8.
  433. Campbell IA, Elmes PC. Ethambutol and the eye: zinc and copper (letter). Lancet 1975;2:711. View abstract.
  434. Mountokalakis T, Dourakis S, Karatzas N, et al. Zinc deficiency in mild hypertensive patients treated with diuretics. J Hypertens Suppl 1984;2:S571-2. View abstract.
  435. Peirce A. The American Pharmaceutical Association Practical Guide to Natural Medicines. New York, NY: William Morrow and Co., 1999.
  436. Bhutta ZA, Black RE, Brown KH, et al. Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized controlled trials. J Pediatr 1999;135:689-97. View abstract.
  437. Penny ME, Peerson JM, Marin RM, et al. Randomized, community-based trial of the effect of zinc supplementation, with and without other micronutrients, on the duration of persistent childhood diarrhea in Lima, Peru. J Pediatr 1999;135:208-17. View abstract.
  438. Hansten PD, Horn JR. Drug Interactions Analysis and Management. Vancouver, WA: Applied Therapeutics Inc., 1997 and updates.
  439. Potocnik FC, van Rensburg SJ, Park C, et al. Zinc and platelet membrane microviscosity in Alzheimer's disease. The in vivo effect of zinc on platelet membranes and cognition. S Afr Med J 1997;87:1116-9. View abstract.
  440. Naveh Y, Schapira D, Ravel Y, et al. Zinc metabolism in rheumatoid arthritis: plasma and urinary zinc and relationship to disease activity. J Rheumatol 1997;24:643-6. View abstract.
  441. Henderson LM, Brewer GJ, Dressman JB, et al. Effect of intragastric pH on the absorption of oral zinc acetate and zinc oxide in young healthy volunteers. JPEN J Parenter Enteral Nutr 1995;19:393-7. View abstract.
  442. Duisterwinkel FJ, Wolthers BG, Koopman BJ, et al. Bioavailability of orally administered zinc, using Taurizine. Pharm Weekbl Sci 1986;8:85-8. View abstract.
  443. Beutler KT, Pankewycz O, Brautigan DL. Equivalent uptake of organic and inorganic zinc by monkey kidney fibroblasts, human intestinal epithelial cells, or perfused mouse intestine. Biol Trace Elem Res 1998;61:19-31. View abstract.
  444. Agren MS. Studies on zinc in wound healing. Acta Derm Venereol Suppl (Stockh) 1990;154:1-36. View abstract.
  445. Young B, Ott L, Kasarskis E, et al. Zinc supplementation is associated with improved neurologic recovery rate and visceral protein levels of patients with severe closed head injury. J Neurotrauma 1996;13:25-34. View abstract.
  446. Rittenhouse T. The management of lower-extremity ulcers with zinc-saline wet dressings versus normal saline wet dressings. Adv Ther 1996;13:88-94. View abstract.
  447. Brewer GJ, Dick RD, Johnson VD, et al. Treatment of Wilson's disease with zinc: XV long-term follow-up studies. J Lab Clin Med 1998;132:264-78. View abstract.
  448. Sturniolo GC, Mestriner C, Irato P, et al. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients. Am J Gastroenterol 1999;94:334-8. View abstract.
  449. Borroni G, Brazzelli V, Vignati G, et al. Bullous lesions in acrodermatitis enteropathica. Histopathologic findings regarding two patients. Am J Dermatopathol 1992;14:304-9. View abstract.
  450. Koletzko B, Bretschneider A, Bremer HJ. Fatty acid composition of plasma lipids in acrodermatitis enteropathica before and after zinc supplementation. Eur J Pediatr 1985;143:310-4. View abstract.
  451. Walldius G, Michaelsson G, Hardell LI, Aberg H. The effects of diet and zinc treatment on the fatty acid composition of serum lipids and adipose tissue and on serum lipoproteins in two adolescent patients with acrodermatitis enteropathica. Am J Clin Nutr 1983;38:512-22. View abstract.
  452. Habbema L, Koopmans B, Menke HE, et al. A 4% erythromycin and zinc combination (Zineryt) versus 2% erythromycin (Eryderm) in acne vulgaris: a randomized, double-blind comparative study. Br J Dermatol 1989;121:497-502. View abstract.
  453. Schachner L, Eaglstein W, Kittles C, Mertz P. Topical erythromycin and zinc therapy for acne. J Am Acad Dermatol 1990;22:253-60. View abstract.
  454. Dreno B, Trossaert M, Boiteau HL, Litoux P. Zinc salts effects on granulocyte zinc concentration and chemotaxis in acne patients. Acta Derm Venereol 1992;72:250-2. View abstract.
  455. Lomaestro BM, Bailie GR. Absorption interactions with fluoroquinolones. 1995 update. Drug Saf 1995;12:314-33. View abstract.
  456. Fosmire GJ. Zinc toxicity. Am J Clin Nutr 1990;51:225-7. View abstract.
  457. Brewer GJ, Yuzbasiyan-Gurkan V, Johnson V, et al. Treatment of Wilson's disease with zinc: XI. Interaction with other anticopper agents. J Am Coll Nutr 1993;12:26-30. View abstract.
  458. Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore, MD: Williams & Wilkins, 1999.
  459. Chan S, Gerson B, Subramaniam S. The role of copper, molybdenum, selenium, and zinc in nutrition and health. Clin Lab Med 1998;18:673-85. View abstract.
  460. Hebel SK, ed. Drug Facts and Comparisons. 52nd ed. St. Louis: Facts and Comparisons, 1998.
  461. Freeland-Graves JH, Lin PH. Plasma uptake of manganese as affected by oral loads of manganese, calcium, milk, phosphorus, copper, and zinc. J Am Coll Nutr 1991;10:38-43. View abstract.
  462. Strause L, Saltman P, Smith KT, et al. Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals. J Nutr 1994;124:1060-4. View abstract.
  463. Hahn CJ, Evans GW. Absorption of trace metals in the zinc-deficient rat. Am J Physiol 1975;228:1020-3. View abstract.
  464. Zhou JR, Erdman JW Jr. Phytic acid in health and disease. Crit Rev Food Sci Nutr 1995;35:495-508. View abstract.
  465. Kugelmas M. Preliminary observation: oral zinc sulfate replacement is effective in treating muscle cramps in cirrhotic patients. J Am Coll Nutr 2000;19:13-5. View abstract.
  466. McKenna AA, Ilich JZ, Andon MB, et al. Zinc balance in adolescent females. Am J Clin Nutr 1997;65:1460-4. View abstract.
  467. Cohanim M, Yendt ER. The effects of thiazides on serum and urinary zinc in patients with renal calculi. Johns Hopkins Med J 1975;136:137-44. View abstract.
  468. Reyes AJ, Olhaberry JV, Leary WP, et al. Urinary zinc excretion, diuretics, zinc deficiency and some side-effects of diuretics. S Afr Med J 1983;64:936-41. View abstract.
  469. Blondeau JM. Expanded activity and utility of the new fluoroquinolones: a review. Clin Ther 1999;21:3-40. View abstract.
  470. Sazawal S, Black RE, Bhan MK, et al. Zinc supplementation in young children with acute diarrhea in India. N Engl J Med 1995;333:839-44. View abstract.
  471. Roy SK, Tomkins AM, Akramuzzaman SM, et al. Randomized, controlled trial of zinc supplementation in malnourished Bangladeshi children with acute diarrhea. Arch Dis Child 1997;77:196-200. View abstract.
  472. Faruque AS, Mahalanabis D, Haque SS, et al. Double-blind, randomized, controlled trial of zinc or vitamin A supplementation in young children with acute diarrhea. Acta Paediatr 1999;88:154-60. View abstract.
  473. Fortes C, Forastiere F, Agabiti N, et al. The effect of zinc and vitamin A supplementation on immune response in an older population. J Am Geriatr Soc 1998;46:19-26. View abstract.
  474. Anderson LA, Hakojarvi SL, Boudreaux SK. Zinc acetate treatment in Wilson's disease. Ann Pharmacother 1998;32:78-87. View abstract.
  475. Hoogenraad TU, Van Hattum J, Van den Hamer CJ. Management of Wilson's disease with zinc sulphate. Experience in a series of 27 patients. J Neurol Sci 1987;77:137-46. View abstract.
  476. Mostafa WZ, al-Zayer AA. Acrodermatitis enteropathica in Saudi Arabia. Int J Dermatol 1990;29:134-8. View abstract.
  477. Feucht CL, Allen BS, Chalker DK, et al. Topical erythromycin with zinc in acne. A double-blind controlled study. J Am Acad Dermatol 1980;3:483-91. View abstract.
  478. Pierard-Franchimont C, Goffin V, Visser JN, et al. A double-blind controlled evaluation of the sebosuppressive activity of topical erythromycin-zinc complex. Eur J Clin Pharmacol 1995;49:57-60. View abstract.
  479. Sandstead HH. Requirements and toxicity of essential trace elements, illustrated by zinc and copper. Am J Clin Nutr 1995;61:621S-4S. View abstract.
  480. Broun ER, Greist A, Tricot G, Hoffman R. Excessive zinc ingestion. A reversible cause of sideroblastic anemia and bone marrow depression. JAMA 1990;264:1441-3. View abstract.
  481. Burnham TH, ed. Drug Facts and Comparisons, Updated Monthly. Facts and Comparisons, St. Louis, MO.
  482. Whitney E, Cataldo CB, Rolfes SR, eds. Understanding Normal and Clinical Nutrition. Belmont, CA: Wadsworth, 1998.
  483. Macknin ML, Piedmonte M, Calendine C, et al. Zinc gluconate lozenges for treating the common cold in children: a randomized, controlled trial. JAMA 1998;279:1962-7. View abstract.
  484. Eby GA. Zinc ion availability--the determinant of efficacy in zinc lozenge treatment of common colds. J Antimicrob Chemother 1997;40:483-93. View abstract.
  485. Weismann K, Jakobsen JP, Weismann JE, et al. Zinc gluconate lozenges for common cold. A double-blind clinical trial. Dan Med Bull 1990;37:279-81. View abstract.
  486. Smith DS, Helzner EC, Nuttall CE Jr, et al. Failure of zinc gluconate in treatment of acute upper respiratory tract infections. Antimicrob Agents Chemother 1989;33:646-8. View abstract.
  487. Farr BM, Conner EM, Betts RF, et al. Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds. Antimicrob Agents Chemother 1987;31:1183-7. View abstract.
  488. Eby GA, Davis DR, Halcomb WW. Reduction in duration of common colds by zinc gluconate lozenges in a double-blind study. Antimicrob Agents Chemother 1984;25:20-4. View abstract.
  489. Al-Nakib W, Higgins PG, Barrow I, et al. Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges. J Antimicrob Chemother 1987;20:893-901. View abstract.
  490. Godfrey JC, Conant Sloane B, Smith DS, et al. Zinc gluconate and the common cold: a controlled clinical study. J Int Med Res 1992;20:234-6. View abstract.
  491. Mossad SB, Macknin ML, Medendorp SV, Mason P. Zinc gluconate lozenges for treating the common cold. A randomized, double-blind, placebo-controlled study. Ann Intern Med 1996;125:81-8. View abstract.
  492. Barceloux DG. Zinc. J Toxicol Clin Toxicol 1999;37:279-92. View abstract.
  493. Zarembo JE, Godfrey JC, Godfrey NJ. Zinc(II) in saliva: determination of concentrations produced by different formulations of zinc gluconate lozenges containing common excipients. J Pharm Sci 1992;81:128-30.. View abstract.
  494. Golik A, Modai D, Averbukh Z, et al. Zinc metabolism in patients treated with captopril versus enalapril. Metabolism 1990;39:665-7. View abstract.
  495. Golik A, Zaidenstein R, Dishi V, et al. Effects of captopril and enalapril on zinc metabolism in hypertensive patients. J Am Coll Nutr 1998;17:75-8. View abstract.
  496. McKevoy GK, ed. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, 1998.
  497. Leung AY, Foster S. Encyclopedia of Common Natural Ingredients Used in Food, Drugs and Cosmetics. 2nd ed. New York, NY: John Wiley & Sons, 1996.
Show more references
Show fewer references
Last reviewed - 10/21/2014




Page last updated: 10 December 2014